levodopa and Tremor
levodopa has been researched along with Tremor in 335 studies
Research
Studies (335)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 91 (27.16) | 18.7374 |
| 1990's | 62 (18.51) | 18.2507 |
| 2000's | 85 (25.37) | 29.6817 |
| 2010's | 65 (19.40) | 24.3611 |
| 2020's | 32 (9.55) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Constantinescu, M; Nassar, M; Schlesinger, I; Sinai, A; Sprecher, E; Zaaroor, M | 1 |
| Che, NN; Chen, SY; Li, X; Ma, JJ; Yang, HQ | 1 |
| Merello, M; Perez-Lloret, S; Rossi, M | 1 |
| Emrick, L; Hull, M; Parnes, M; Sadat, R | 1 |
| Bai, X; Chen, J; Gao, T; Gu, L; Gu, Q; Guan, X; Guo, T; Huang, P; Liu, X; Pu, J; Song, Z; Wen, J; Wu, H; Wu, J; Xu, X; Xuan, M; Zhang, B; Zhang, M; Zhou, C | 1 |
| Errico, V; Giannini, F; Lazzaro, GD; Pisani, A; Ricci, M; Saggio, G | 1 |
| Hu, BL; Huang, JF; Huang, SS; Liu, RP; Wang, JY; Zhang, X; Zhu, JH; Zhu, SG | 1 |
| Chan, J; Goetz, CG; Luo, S; Macklin, EA; Oakes, D; Schwarzschild, MA; Simuni, T; Stebbins, GT; Zou, H | 1 |
| Amami, P; Bocchi, E; Bonvegna, S; Bruzzone, MG; Ciceri, EFM; Cilia, R; Devigili, G; Eleopra, R; Elia, AE; Gasparini, V; Ghielmetti, F; Golfrè Andreasi, N; Grisoli, M; Levi, V; Messina, G; Novelli, A; Piacentini, SHMJ; Prioni, S; Rinaldo, S; Romito, LM; Stanziano, M; Straccia, G; Tringali, G | 1 |
| Biskup, S; Fietzek, UM; Mueller, C; Schneider, SA; Schroeder, AS | 1 |
| Abusrair, AH; Bohlega, S; Elsekaily, W | 1 |
| Bloem, BR; Boel, JA; de Bie, RMA; de Haan, RJ; Deuschl, G; Dijk, JM; Dijkgraaf, MGW; Frequin, HL; Lang, A; Munts, AG; Post, B; Schouten, J; Suwijn, SR; Tissingh, G; van Hilten, JJ; van Laar, T; Verschuur, CVM | 1 |
| Gu, SC; Shi, R; Wang, CD; Wu, Y; Yang, YW; Ye, Q; Yuan, CX; Zhang, Y | 1 |
| Han, XM; Li, YP; Liu, BP; Wang, RF; Wang, Z; Xu, SS; Zhang, HY | 1 |
| Chung, SJ; Hwang, YS; Jeon, SR; Jo, S; Kim, MS; Kim, N; Lee, SH | 1 |
| Aguado-Carrillo, G; Armas-Salazar, A; Beltrán, JQ; Carrillo-Ruiz, JD; Jiménez-Ponce, F; Navarro-Olvera, JL; Velasco-Campos, F | 1 |
| Hallett, M; Katzenschlager, R; Pirker, W; Poewe, W | 1 |
| Mügge, F; Pedrosa, AJ; Pedrosa, DJ; Timmermann, L; Waldthaler, J | 1 |
| Arif, C; Koneru, V; Ondo, WG | 1 |
| Fuller, L; Wexler, RS | 1 |
| Bloem, BR; Dirkx, MF; Helmich, RC; Toni, I; van Nuland, A; Zach, H | 1 |
| Mannoury-la-Cour, C; Mantas, I; Millan, MJ; Svenningsson, P; Yang, Y; Zhang, X | 1 |
| Ayala, A; Forjaz, MJ; Harmat, M; Janszky, J; Juhász, A; Kovács, N; Martinez-Martin, P; Pintér, D; Rodriguez-Blazquez, C | 1 |
| Chang, CM; Chen, JC; Huang, YL; Lee, CC | 1 |
| Carbunaru, S; Eisinger, RS; Hess, CW; Hu, W; Okun, MS; Ramirez-Zamora, A; Shukla, AW; Smith, C; Wang, KL; Wong, JK | 1 |
| Bloem, BR; Dirkx, MF; Helmich, RC; Pasman, JW; Roth, D; Zach, H | 1 |
| Fransson, PA; Johansson, R; Magnusson, M; Nilsson, MH; Patel, M; Rehncrona, S; Tjernström, F | 1 |
| Kobylecki, C | 1 |
| Duprez, T; Lawson, TM; Lejeune, T; Peeters, A; Slootjes, SM | 1 |
| Claus, I; Dziewas, R; Labeit, B; Muhle, P; Suntrup-Krueger, S; Suttrup, J; Warnecke, T | 1 |
| Batra, D; Bhattacharya, A; Holla, VV; Kamble, N; Pal, PK; Prasad, S; Sahoo, LK; Yadav, R | 1 |
| Cools, R; den Ouden, HEM; Dirkx, MF; Helmich, RC; Toni, I; van Nuland, AJ; Zach, H | 1 |
| Ghosh, S; Malaty, I; Salamatova, Y | 1 |
| Bloem, BR; Klein, C; Okun, MS | 1 |
| Jankovic, J; Tarakad, A | 1 |
| Bhatkar, SR; Bhonsle, SK; de Souza, A; Fernandes, YS | 1 |
| Chang, MC; Lee, HD | 1 |
| Esqueda-Liquidano, M; García-Gomar, MG; Velasco, AL; Velasco, F | 1 |
| Bloem, BR; Dirkx, MF; Hallett, M; Helmich, RC; Zach, H | 1 |
| Belvisi, D; Berardelli, A; Conte, A; Costanzo, M; Cutrona, C; Fabbrini, G; Ferrazzano, G | 1 |
| Gooneratne, IK; Udagedara, TB | 1 |
| Brodie, MA; Fung, VSC; Latt, MD; Lord, SR; Menant, JC; Menz, HB; Pelicioni, PHS | 1 |
| Irioka, T; Ishibashi, S; Miura, M; Nishida, Y; Numasawa, Y; Ozaki, K; Takahisa, M; Yokota, T | 1 |
| Hallett, M; Merello, M; Rivero, AD; Rossi, MD; Wilken, M | 1 |
| Hamel, W; Hariz, M; Köppen, JA; Krack, P; Moll, CKE; Müller, D | 1 |
| Reich, SG; Savitt, JM | 1 |
| Konishi, O; Manabe, Y; Odawara, T | 1 |
| Farzanehfar, P; Horne, M; Khodakarami, H | 1 |
| Borroni, B; Cotelli, MS; Filosto, M; Marchina, E; Padovani, A; Premi, E | 1 |
| Fox, SH | 1 |
| Burack, MA; Giuffrida, JP; Mera, TO | 1 |
| Dronamraju, N; Graf, A; Hauser, RA; Kenney, C; Kumar, R; Merschhemke, M; Mostillo, J | 1 |
| Benecke, R; Walter, U; Wittstock, M; Wolters, A | 1 |
| Armentero, MT; Baqi, Y; Bonaventura, J; Canela, EI; Casadó, V; Cortés, A; Costa, G; Farré, D; Franco, R; Lanciego, JL; Lluís, C; Mallol, J; Martínez-Pinilla, E; McCormick, P; Müller, CE; Pinna, A; Sánchez, M; Simola, N | 1 |
| Hu, X; Huang, B; Li, H; Ma, Y; Rizak, JD; Yan, T; Yang, S | 1 |
| Ahonen, A; Airaksinen, K; Luoma, J; Mäkelä, JP; Nurminen, J; Pekkonen, E; Taulu, S | 1 |
| Huot, P; Huynh, NT | 1 |
| Baumann, CR; Gassert, R; Imbach, LL; Leuenberger, K; Maier, O; Schreglmann, SR; Sommerauer, M; Uhl, M | 1 |
| Akram, H; Angeli, A; Foltynie, T; Hariz, M; Limousin, P; Zacharia, A; Zrinzo, L | 1 |
| Chen, B; Hou, Y; Wu, T; Zhang, J | 1 |
| Acs, P; Bokor, M; Bosnyák, E; Deli, G; Dibó, G; Herceg, M; Hidasi, E; Horvath, K; Imre, P; Késmárki, I; Klivényi, P; Komoly, S; Kovács, N; Lajtos, J; Nagy, F; Pál, E; Rigó, E; Takács, K; Takáts, A; Tóth, A; Vécsei, L | 1 |
| Chen, HM; Fang, JP; Feng, T; Gao, LY; Hou, YN; Ma, LY; Wang, ZJ; Wu, T; Zhang, JR | 1 |
| Titova, NV | 1 |
| Alexander, SA; Gopalakrishna, A | 1 |
| Livi, L; Sadeghian, A; Sadeghian, H | 1 |
| Cristovam, Rdo A; Fussiger, H; Marrone, AC; Marrone, LC; Martins, WA; Taietti, MZ; Vedana, VM | 1 |
| Calandra, C; Calvo, DS; Cersosimo, MG; Fernandez Pardal, MM; Folgar, SS; Giannaula, RJ; Giugni, JC; Micheli, FE; Paviolo, JP; Pellene, LA; Raina, GB; Tkachuk, VA; Tschopp, AL; Uribe Roca, MC; Velez, M; Zuñiga Ramirez, C | 1 |
| Algom, AA; Dickson, DW; Fujioka, S; Murray, ME; Rademakers, R; Ross, OA; Sanchez-Contreras, MY; Tacik, P; Tsuboi, Y; Uitti, RJ; Van Gerpen, JA; Wszolek, ZK | 1 |
| Cerquetti, D; Fariña, S; Merello, M; Morisset, P; Rossi, M; Wilken, M | 1 |
| Chiou, SM | 1 |
| Bloem, BR; Dirkx, M; Helmich, RC; Pasman, JW; Zach, H | 1 |
| Akbostanci, MC; Aytürk, Z; Yilmaz, R | 1 |
| Bloem, BR; Dirkx, MF; Helmich, RC; Pasman, JW; Zach, H | 1 |
| Mizuno, Y; Origasa, H; Shimoda, S | 1 |
| Grabli, D | 1 |
| Berman, BD; Mohl, B; Shelton, E; Tanabe, J | 1 |
| Betz, AJ; Bibbiani, F; Chase, TN; Davis, RE; Kielaite, A; Salamone, JD; Vanover, KE; Weber, SM; Weiner, DM | 1 |
| Miyashita, Y; Saiki, A; Sakakibara, R; Shirai, K; Tateno, F | 1 |
| Agid, Y; Bonnet, AM; Cornu, P; Dormont, D; El Otmani, H; Jodoin, N; Navarro, S; Pidoux, B; Welter, ML; Yaici, S | 1 |
| Butz, M; Gross, J; Makhloufi, H; Pollok, B; Schnitzler, A; Timmermann, L; Wojtecki, L | 1 |
| Aasly, JO; Beiske, AG; Bekkelund, SI; Dietrichs, E; Larsen, JP; Tysnes, OB; Vilming, ST | 1 |
| Bayliss, M; Harper, A; Nisbet, A; Saha, R; Scutt, A | 1 |
| Berciano, J; Bonifati, V; Breedveld, G; Di Fonzo, A; García, A; Infante, J; Oostra, B; Sánchez-Juan, P | 1 |
| Jeon, BS; Kim, DG; Kim, HJ; Kim, JY; Lee, JY; Lim, YH; Paek, SH | 1 |
| Kim, DG; Kim, OJ; Koo, YH; Oh, SH | 1 |
| Bodenheimer, RE; Davis, TL; Dawant, BM; Li, R; Rao, AS; Voight, C | 1 |
| Broussolle, E; Gan, J; Gervais-Bernard, H; Thobois, S; Vallet, AE; Xie-Brustolin, J | 1 |
| Fernandez, HH; Foote, KD; Garvan, CW; Haq, IU; Hass, CJ; Jacobson, CE; Malaty, IA; Mann, JM; Morishita, T; Okun, MS; Rodriguez, RL; Siddiqui, MS | 1 |
| Chen, SY; Chou, YC; Hung, HY; Li, CW; Lin, SH; Lin, SZ; Pan, YH; Tsai, ST | 1 |
| Benamer, HT; Grosset, DG; Kalra, S | 1 |
| Artemova, IIu; Boĭko, AN; Ganzhula, PA; Ismailov, AM; Ivanov, AK; Khozova, AA; Levin, OS; Lisenker, LN; Nesterova, OS; Otcheskaia, OV; Rotor, LD; Vdovichenko, TV; Zhuravleva, EIu | 1 |
| Nowak, DA; Reiner, B; Seidel, B | 1 |
| Mink, JW; Zinner, SH | 1 |
| Bugalho, P; da Silva, JA; Neto, B | 1 |
| Bugalho, P; Lampreia, T; Santos, L; Soares, P | 1 |
| Alterman, R; Martin, C; Tagliati, M | 1 |
| Kim, BJ; Kim, JS; Kim, KK; Kim, SM; Lee, MC; Lim, YM; Park, HK | 1 |
| Dick, OE; Nozdrachev, AD; Romanov, SP | 1 |
| Ahlskog, JE; Josephs, KA; Klassen, BT; Lee, KH; Matsumoto, JY; Savica, R; Stead, M | 1 |
| Ballinari, P; Kaelin-Lang, A; Kipfer, S; Schüpbach, WM; Stephan, MA | 1 |
| Rabey, JM; Stocchi, F | 1 |
| Schnitzler, A; Südmeyer, M; Wojtecki, L | 1 |
| Åström, M; Blomstedt, P; Forsgren, L; Fytagoridis, A; Hariz, MI; Linder, J | 1 |
| Chung, SJ; Kim, J; Kim, JS; Kim, KK; Lee, CS; Lim, YM; Park, HK | 1 |
| Dunn, E; Espay, AJ; Gallin, E; Li, JY; Litvan, I; Morgante, F; Munhoz, RP; Teive, HA | 1 |
| Boelmans, K; Gerloff, C; Münchau, A | 1 |
| Barbe, MT; Eggers, C; Pauls, KA; Salimi Dafsari, H; Timmermann, L | 1 |
| Filipović, SR; Kačar, A; Kostić, VS; Kresojević, N; Ljubisavljević, M; Milanović, SD; Rothwell, JC | 1 |
| Abdolahi, A; Biglan, KM; Dorsey, ER; Killoran, A; Scoglio, N | 1 |
| Antonini, A; Bonanni, L; Onofrj, M; Perfetti, B; Petrucci, S; Stocchi, F; Taylor, JP; Thomas, A; Valente, EM; Varanese, S | 1 |
| Liou, HH; Liu, HM; Su, PC; Tseng, HM; Yen, RF | 2 |
| Ohye, C; Shibazaki, T | 1 |
| Aleksanian, ZA; Manoĭlov, VV; Romanov, SP | 1 |
| Angelini, L; Blau, N; Fernandez Alvarez, E; Garavaglia, B; Invernizzi, F; Nardocci, N; Pannacci, M; Sesta, M; Zorzi, G | 1 |
| Minagar, A; Shulman, LM; Weiner, WJ | 1 |
| Bhatia, K; Brown, P; Costa, D; Gacinovic, S; Gerschlager, W; Katzenschlager, R; Lees, AJ; O'Sullivan, J; Pirker, W; Wills, A; Zijlmans, J | 1 |
| Bankiewicz, KS; Emborg, ME; McLaughlin, WW; Moirano, J; Tetrud, JW | 1 |
| Bakay, RA; Barnhart, H; Chockkan, V; DeLong, MR; Evatt, M; Freeman, A; Green, J; Haber, M; McDonald, W; Mewes, K; Triche, S; Vitek, JL; Wahlay, N; Zhang, JY | 1 |
| Bembi, B; Capus, L; Carrozzi, M; Ciana, G; Gioulis, M; Martini, C; Pittis, MG; Sidransky, E; Zambito Marsala, S; Zorzon, M | 1 |
| Sethi, KD | 1 |
| Balash, Y; Bartels, AL; Giladi, N; Gurevich, T; Hausdorff, JM; Schaafsma, JD | 1 |
| Kohmoto, J; Kondo, T; Miwa, H; Nakanishi, I | 1 |
| Shinohara, Y; Takahashi, H | 1 |
| BARRE, N; CAHN, J; HEROLD, M | 1 |
| HIRSCHMANN, J; MAYER, K | 1 |
| Decamp, E; Gonczi, H; Schneider, JS | 1 |
| Agid, Y; Bonnet, AM; Cornu, P; Duyckaerts, C; Hauw, JJ; Houeto, JL; Jarraya, B | 1 |
| Pagni, CA; Zeme, S; Zenga, F | 1 |
| Aubin, N; Barneoud, P; Burnier, P; Caille, D; Carter, C; Charieras, T; Curet, O; Gardes, A; George, P; Jegham, S; Le Kim, A; Lolivier, J; Marc, C; Pandini, M; Perron, C; Puech, F; Scatton, B; Sontag, N | 1 |
| Bird, TD; Bower, J; Calne, DB; de la Fuente-Fernandez, R; Farrer, M; Furtado, S; Gwinn-Hardy, K; Hanson, M; Hardy, J; Klimek, ML; Lockhart, PJ; Nutt, JG; Payami, H; Singleton, A; Singleton, AA; Stoessl, AJ; Suchowersky, O; Tsuboi, Y; Utti, RJ; Wszolek, ZK | 1 |
| Gross, J; Lehrke, R; Maarouf, M; Schnitzler, A; Sturm, V; Timmermann, L; Treuer, H; Voges, J; Wojtecki, L | 1 |
| Ferraz, HB; Nova, IC; Perracini, MR | 1 |
| Kang, SY; Lee, MH; Lee, SK; Sohn, YH | 1 |
| Chu, NS | 1 |
| Magnani, P; Mailland, E; Ottillinger, B | 1 |
| Widnell, K | 1 |
| Anderson, VC; Burchiel, KJ; Favre, J; Hammerstad, JP; Hogarth, P | 1 |
| Aasly, JO; Farrer, M; Fernandez-Mata, I; Hulihan, M; Kachergus, J; Toft, M; White, LR | 1 |
| Deuschl, G; Govindan, RB; Morsnowski, A; Pohle, S; Raethjen, J; Wenzelburger, R | 1 |
| Glover, AL; Iyer, SS; Morgan, JC; Sethi, KD | 1 |
| Bakay, RA; Corcos, DM; Metman, LV; Prodoehl, J; Sturman, MM; Vaillancourt, DE | 1 |
| Gielen, SC; Horstink, MW; Keijsers, NL | 1 |
| Baba, Y; Putzke, JD; Uitti, RJ; Whaley, NR; Wszolek, ZK | 1 |
| Bhat, V; Weiner, WJ | 1 |
| Hattori, N; Inzelberg, R; Mizuno, Y | 1 |
| Apetauerova, D; Corapi, K; Norregaard, T; O'Herron, S; Scollins, L; Tarsy, D | 1 |
| Linazasoro, G; Magariños, C; Van Blercom, N | 1 |
| Berry-Kravis, E; Hagerman, PJ; Hagerman, RJ; Hall, DA; Leehey, MA; Rice, CD | 1 |
| Bain, PG; Hensman, DJ | 1 |
| Giladi, N; Gurevich, TY; Korczyn, AD; Shabtai, H; Simon, ES | 1 |
| Dostrovsky, JO; Hodaie, M; Hutchison, WD; Lang, AE; Lozano, AM; Mahant, N; Moro, E; Weinberger, M | 1 |
| Weiner, WJ | 1 |
| Deuschl, G; Raethjen, J | 1 |
| Bäzner, H; Blahak, C; Capelle, HH; Grips, E; Hennerici, MG; Krauss, JK; Weigel, R; Wöhrle, JC | 1 |
| Carlson, NE; Carter, JH; Nutt, JG | 1 |
| Borsini, F; Carminati, P; Frau, L; Morelli, M; Schintu, N; Simola, N; Tronci, E | 1 |
| Benecke, R; Wolters, A | 1 |
| Chung, SJ; Kim, SR; Lee, MC; Sung, YH | 1 |
| Goto, S; Hamasaki, T; Kuratsu, JI; Yamada, K | 1 |
| Caltagirone, C; Chiavalon, C; Fermi, E; Gasbarra, A; Mazzone, P; Peppe, A; Pierantozzi, M; Stanzione, P; Stefani, A | 1 |
| Anderson, KE; Fishman, PS; Gruber-Baldini, AL; Reich, SG; Shulman, LM; Vaughan, CG; Weiner, WJ | 1 |
| Austermann, K; Deuschl, G; Papengut, F; Raethjen, J; Witt, K; Zeuner, KE | 1 |
| Auff, E; Kasprian, G; Leutmezer, F; Prayer, D; Seidel, S | 1 |
| Massey, EW; Riley, TL | 1 |
| Jörg, J | 1 |
| Selby, G | 1 |
| Cleveland, S; Ganguly, DK; Ross, HG | 1 |
| Berkovic, SF; Bladin, PF | 1 |
| Narabayashi, H | 3 |
| Lucas, TS; Quock, RM | 2 |
| Calne, DB; Newman, RP | 1 |
| Agnoli, A; Baldassarre, M; D'Urso, R; Del Roscio, S; Falaschi, P; Frajese, G; Mearelli, S; Rocco, A; Ruggieri, S | 1 |
| Pilc, A; Rogóz, Z; Skuza, G | 1 |
| Bergsrud, D; Elton, RL; Racy, A; Teychenne, PF; Vern, B | 1 |
| Bernstein, JE; Lorincz, AL; Medenica, M; Solomon, A; Soltani, K | 1 |
| Findley, LJ; Gresty, MA | 1 |
| Yuill, GM | 2 |
| Dostrovsky, JO; Duff, J; Galvez-Jimenez, N; Hutchinson, WD; Lang, AE; Lozano, AM; Miyasaki, J | 1 |
| Iacono, RP; Lonser, RR; Oh, A; Yamada, S | 1 |
| Arnold, G; Bandmann, O; Bondy, B; Gasser, T; Oertel, WH; Poewe, W; Schwarz, J; Trenkwalder, C; Wagner, M | 1 |
| Caparros-Lefebvre, D; Duhamel, A; Pécheux, N; Petit, H; Petit, V | 1 |
| Bhatia, M; Jain, S; Maheshwari, MC | 1 |
| Linazasoro, G | 1 |
| Arnold, G; Oertel, WH; Schwarz, J; Trenkwalder, C | 1 |
| Ben Shlomo, Y; Daniel, SE; Magalhães, M; Quinn, NP; Wenning, GK | 1 |
| Aronowitz, JS; Gordon, MF; Kane, JM; Lieberman, JA; Pollack, S; Safferman, AZ | 1 |
| Defer, GL; Degos, JD; Malapert, D; Remy, P; Ricolfi, F; Samson, Y | 1 |
| Caligiuri, MP; Peterson, S | 1 |
| Kiauta, T; Mesec, A; Sega, S | 1 |
| Auff, E; Doppelbauer, A; Fertl, E; Waldhauser, F | 1 |
| Albani, C; Buck, A | 1 |
| Baas, H; Fischer, PA; Stecker, K | 1 |
| Blond, S; Caparros-Lefebvre, D; Guieu, JD; Pécheux, N; Petit, H; Vermersch, P | 1 |
| Hadar, U; Rose, FC | 1 |
| Caraceni, T; Fetoni, V; Geminiani, GC; Genitrini, S; Giovannini, P; Girotti, F; Parati, EA; Soliveri, P; Testa, D | 1 |
| Benson, R; Charlton, CG; Crowell, BG; Shockley, D | 1 |
| Caligiuri, MP; Lohr, JB | 1 |
| Falk, M; Künig, G; Neubauer, M; Ransmayr, G; Wagner, M | 1 |
| Byth, K; Einstein, R; Henderson, JM; Jackson, DM; Morris, JG | 1 |
| Burleigh, A; Frank, J; Horak, F; Nutt, J | 1 |
| Felice, KJ; Grunnet, ML | 1 |
| Furukawa, Y; Mizuno, Y; Narabayashi, H | 1 |
| DeCarvalho, GC; Kestle, JR; Li, CS; Tasker, RR | 1 |
| Antonijoan, R; Arcelus, R; Avila, A; Barbanoj, M; Kulisevsky, J; Torres, J | 1 |
| Hirato, M; Horikoshi, S; Ishihara, J; Ohye, C; Shibazaki, T | 1 |
| Charlton, CG; Crowell, B | 2 |
| Adena, MA; Broe, GA; Hely, MA; Morris, JG; O'Sullivan, DJ; Reid, WG; Williamson, PM | 1 |
| Caparros-Lefebvre, D; Duffau, H; Mazoyer, B; Parker, F; Tzourio, N | 1 |
| Fahn, S; Klatka, LA; Liu, Y; Louis, ED | 1 |
| Fukuzaki, K; Kitahara, K; Kohno, Y; Koja, T | 1 |
| Hariz, M; Johansson, F; Malm, J; Nordh, E | 1 |
| Bakke, SJ; Nyberg-Hansen, R; Shepherd, GM; Tauböll, E | 1 |
| Tashiro, K | 1 |
| Bünger, N; Jeune, B; Joensen, P; Wermuth, L | 1 |
| Byth, K; Einstein, R; Henderson, JM; Jackson, D; Morris, JG; Yiannikas, C | 1 |
| Bioulac, B; Boraud, T; Gross, C; Guehl, D; Julien, J; Rougier, A | 1 |
| de Yébenes, JG; García-Ruiz, PJ; Sánchez-Pernaute, R | 1 |
| Birdi, S; Fenton, Me; Macaulay, R; Rajput, AH | 1 |
| Hirano, M; Imaiso, Y; Kaneda, N; Kira, J; Taniwaki, T; Ueno, S; Yamada, T; Yoshimura, T | 1 |
| Chokroverty, S; Masdeu, JC; Sander, HW; Tavoulareas, G; Walters, A; Zimmerman, T | 1 |
| Blasko, J; Burkhart, WA; Goiney, RC; Grimm, P; Posewitz, A; Shumway-Cook, A; Vermeulen, SS; Young, RF | 1 |
| Adler, C; Crook, R; DeVrieze, FW; Farrer, M; Gwinn-Hardy, K; Hardy, J; Lincoln, S; MacElwee, K; Maraganore, D; McCarthy, P; Miller, C; Muenter, M; Newman, S; Perez-Tur, J; Waters, C | 1 |
| Gelb, DJ; Gilman, S; Oliver, E | 1 |
| Brown, P; Brusa, L; Marsden, CD; Wang, HC; Wills, AJ | 1 |
| Breit, S; Dichgans, J; Klockgether, T; Spieker, S | 1 |
| Hagenah, J; Klein, C; Sieberer, M; Vieregge, P | 1 |
| Ingvarsson, PE; Johnels, B; Olsson, T; Steg, G | 1 |
| Hanson, DG; Jiang, J; Lin, E; Wang, J | 1 |
| Drieu, K; Porsolt, RD; Roux, S | 1 |
| Agid, Y; Arnulf, I; Bejjani, BP; Bonnet, AM; Cornu, P; Damier, P; Dormont, D; Marsault, C; Philippon, J; Pidoux, B; Yelnik, J | 1 |
| Saiki, H; Takeuchi, J; Yamagami, T | 1 |
| Katayama, Y | 1 |
| Yokochi, F | 1 |
| Milanov, I | 1 |
| Rajput, AH | 1 |
| Côte, LJ; Fahn, S; Levy, G; Louis, ED; Marder, K; Mejia, H | 1 |
| Ahangar, B; Burke, DT; Chae, H; Frates, EP | 1 |
| Julow, J; Sági, S; Solymosi, D; Valálik, I | 1 |
| Ohye, C | 1 |
| Albanese, A; Bentivoglio, AR; Cortelli, P; Elia, A; Ferraris, A; Ialongo, T; Montagna, P; Valente, EM | 1 |
| Apartis, E; Arné, P; Jedynak, CP; Tison, F; Vidailhet, M | 1 |
| Fukaya, C; Kasai, M; Katayama, Y; Mizutani, T; Ogawa, K; Oshima, H; Yamamoto, T | 1 |
| Kostić, VS; Marinković, J; Przedborski, S; Stefanova, E; Svetel, M | 1 |
| Campos, V; García De Yébenes, J; Mena, MA; Meseguer, E; Sánchez, V; Taboada, R | 1 |
| Elble, RJ | 1 |
| Earl, J; Fung, VS; Grattan-Smith, PJ; Steenbergen-Spanjers, GC; Wevers, RA; Wilcken, B | 1 |
| Keens, J; Schrag, A; Warner, J | 1 |
| Oladeji, O; Padovani, A; Palvarini, L; Pezzini, A; Viale, P; Zavarise, P | 1 |
| Shahani, BT; Young, RR | 1 |
| Battista, AF; Fuxe, K; Goldstein, M; Lew, JY; Lieberman, A; Nakamura, S | 1 |
| Hungerbühler, JP; Regli, F | 1 |
| Charlton, CG; Way, EL | 1 |
| Przuntek, H | 1 |
| Sears, ES | 1 |
| Chrétien, M; Motomatsu, T; Seidah, N | 1 |
| Hökendorf, H | 1 |
| Bathien, N; Rondot, P | 1 |
| Agostini, L; Firenze, C; Gallai, V; Piccinin, GL; Piccirilli, M; Rossi, A | 1 |
| Asano, T; Matsumoto, Y; Mimura, Y; Mino, S; Nishimoto, A; Ohmoto, T; Yoshimura, Y | 1 |
| Yoshida, M | 1 |
| Eshel, Y; Korczyn, AD | 1 |
| Coward, DM; Doggett, NS; Sayers, AC | 1 |
| Chastang, C; Guillard, A | 1 |
| Agnoli, A; Denaro, A; Lelli, A; Ruggieri, S | 1 |
| Carlsson, A | 1 |
| Calne, DB; Kartzinel, R; Shoulson, I | 1 |
| Derome, P; Guiot, G; Robert, G | 1 |
| Boucher, R; Dankova, J; Larochelle, L; Péchadre, JC; Poirier, LJ | 1 |
| Filion, M; Larochelle, L; Péchadre, JC; Poirier, LJ | 1 |
| Anagnoste, B; Battista, AF; Goldstein, M; Ogawa, M | 1 |
| Duvoisin, RC | 1 |
| Kishikawa, H; Namba, S; Omoto, T | 1 |
| de Carolis, AS; de Trujillo, GC; Longo, VG | 1 |
| McKinney, AS | 1 |
| Fleming, AM; Lenman, JA; Reid, A; Turnbull, MJ | 1 |
| Hosaka, A; Imai, H; Miyagawa, F; Nomura, Y; Segawa, M | 1 |
| Gulmann, NC | 1 |
| Chalmers, RJ; Johnson, RH; McLellan, DL | 1 |
| Bathien, N; Dumas, JL; Rondot, P | 1 |
| Asselman, P; Bovill, KT; Marsden, CD; Parkes, JD; Phipps, JA; Rose, P; Tarsy, D | 1 |
| Bastard, J; Chanelet, J; Emile, J; Truelle, JL | 1 |
| Dietrichson, P; Holmsen, R; Presthus, J | 1 |
| Jarcho, LW; Petajan, JH | 1 |
| Silfverskiöld, B | 1 |
| Guillard, A | 1 |
| Mawdsley, C | 1 |
| Costall, B; Kelly, DM; Naylor, RJ | 1 |
| Blond, S; Caparros-Lefebvre, D; Pasquier, F; Pécheux, N; Petit, H | 1 |
| Brooks, DJ; Findley, LJ; Ibanez, V; Marsden, CD; Playford, ED; Sawle, GV; Thompson, PD | 1 |
| Hotta, K; Mizusawa, H; Morita, S; Nagase, T; Omote, M; Sakai, K; Yamane, M | 1 |
| Ahlskog, JE; Fox, MW; Kelly, PJ | 1 |
| Coni, RJ; Cowger, M; Factor, SA; Rosenblum, EL | 1 |
| Hauglie-Hanssen, E; Wester, K | 1 |
| Bonavita, V; Marshall, RW; Sasso, E; Tedeschi, G | 1 |
| Hughes, AJ; Lees, AJ; Stern, GM | 1 |
| Frankel, JP; Hughes, A; Lees, AJ; Stern, GM | 1 |
| Barter, R; Koller, WC; Vetere-Overfield, B | 1 |
| Burton, K | 1 |
| Bratton, M; Jost, MG; Lannon, MC; Lockhart-Pretti, P; Thomas, CA | 1 |
| Ohmoto, T | 1 |
| Longo, VG; Massotti, M | 1 |
| Agnoli, A; Carta, A; Denaro, A; Meco, G; Ruggieri, S; Stocchi, F | 1 |
| Grundmann, M; Schimrigk, K | 1 |
| Klawans, HL | 1 |
| Critchley, P; Marsden, CD; Quinn, N | 1 |
| Herbster, G; Koller, WC | 1 |
| Colpaert, FC | 1 |
| Bergsrud, D; Elton, RL; Racy, A; Teychenne, PF | 1 |
| Indo, T; Takahashi, A | 1 |
| Gerstenbrand, F; Poewe, W | 1 |
| Kobayashi, I; Maruyama, S; Ohta, K; Osawa, M | 1 |
| Feldman, RG; Lannon, MC | 1 |
| Close, SP; Marriott, AS; Pay, S | 1 |
| Poddar, MK; Ray, SK | 1 |
| Koller, WC | 1 |
| Boismare, F; Chadelaud, M; Chretien, P; Daoust, M; Moore, N; Saligaut, C | 1 |
| Caccia, MR; Mangoni, A | 1 |
| Koller, WC; Rubino, FA | 1 |
| Culebras, A; Miller, M | 1 |
| Jacobs, BL | 1 |
| Bédard, P; Boucher, R; Langelier, P; Larochelle, L; Parent, A; Poirier, LJ; Roberge, AG | 1 |
| Poirier, LJ | 1 |
| Marsden, CD | 1 |
| Anagnoste, B; Battista, AF; Fuxe, K; Goldstein, M; Miyamoto, T | 1 |
| Goto, A; Kosaka, K; Miyazaki, S; Narabayashi, H | 1 |
| Javdan, P; Pitman, ER; Weiss, A | 1 |
| Bartholini, G; Bigler, R; Brossi, A; Burns, JJ; Kaiser, A; Pletscher, A; Pool, W; Sheppard, H | 1 |
| Klawans, HL; Topel, JL | 1 |
| Borromei, A; Manzini, A | 1 |
Reviews
40 review(s) available for levodopa and Tremor
| Article | Year |
|---|---|
Parkinsonism-Hyperpyrexia Syndrome and Dyskinesia-Hyperpyrexia Syndrome in Parkinson's Disease: Two Cases and Literature Review.
Topics: Aged; Antiparkinson Agents; Female; Humans; Levodopa; Male; Parkinson Disease; Parkinsonian Disorders; Syndrome; Tremor | 2022 |
Tremor in Parkinson's Disease: From Pathophysiology to Advanced Therapies.
Topics: Botulinum Toxins; Cholinergic Antagonists; Dopamine Agents; Dopamine Agonists; Humans; Levodopa; Parkinson Disease; Tremor | 2022 |
Pharmacological Treatment of Tremor in Parkinson's Disease Revisited.
Topics: Antiparkinson Agents; Apomorphine; Cholinergic Antagonists; Dopamine Agonists; Humans; Levodopa; Parkinson Disease; Tremor | 2023 |
Non-lesional treatments for tremor in Parkinson's disease: A systematic review and meta-analysis.
Topics: Antiparkinson Agents; Dopamine Agonists; Humans; Levodopa; Parkinson Disease; Tremor | 2023 |
Therapeutic Advances in the Treatment of Holmes Tremor: Systematic Review.
Topics: Deep Brain Stimulation; Globus Pallidus; Humans; Levodopa; Thalamic Nuclei; Tremor | 2022 |
Parkinson's disease.
Topics: Antiparkinson Agents; Disease Management; Humans; Levodopa; Parkinson Disease; Prodromal Symptoms; Time Factors; Tremor | 2021 |
Diagnosis and Management of Parkinson's Disease.
Topics: Antiparkinson Agents; Deep Brain Stimulation; Humans; Levodopa; Parkinson Disease; Tremor | 2017 |
The Pioneering and Unknown Stereotactic Approach of Roeder and Orthner from Göttingen. Part II: Long-Term Outcome and Postmortem Analysis of Bilateral Pallidotomy in the Pre-Levodopa Era.
Topics: Adult; Aged; Chorea; Diagnosis; Dyskinesias; Female; Globus Pallidus; Humans; Imaging, Three-Dimensional; Levodopa; Male; Middle Aged; Movement Disorders; Pallidotomy; Parkinson Disease; Psychosurgery; Stereotaxic Techniques; Thalamus; Treatment Outcome; Tremor | 2018 |
Parkinson's Disease.
Topics: Antiparkinson Agents; Deep Brain Stimulation; Diagnosis, Differential; Humans; Hypokinesia; Levodopa; Parkinson Disease; Tremor | 2019 |
Non-dopaminergic treatments for motor control in Parkinson's disease.
Topics: Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Dopamine Agents; Drug Resistance; Dyskinesia, Drug-Induced; Gait Disorders, Neurologic; Humans; Levodopa; Mesencephalon; Molecular Targeted Therapy; Monoamine Oxidase Inhibitors; Neurons; Off-Label Use; Parkinson Disease; Serotonin Antagonists; Tremor | 2013 |
[A current view on dopamine receptor agonists in the treatment of Parkinson's disease].
Topics: Antiparkinson Agents; Benzothiazoles; Controlled Clinical Trials as Topic; Dopamine Agonists; Double-Blind Method; Humans; Levodopa; Parkinson Disease; Pramipexole; Quality of Life; Tremor | 2015 |
Topics: Antiparkinson Agents; Articulation Disorders; Corpus Striatum; Deglutition Disorders; Disease Progression; Dopamine Agonists; Dopaminergic Neurons; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Movement; Muscle Hypertonia; Parkinson Disease; Parkinsonian Disorders; Postural Balance; Sensation Disorders; Substantia Nigra; Tremor | 2017 |
[Motor symptoms in Parkinson disease].
Topics: Age Factors; Antiparkinson Agents; Deep Brain Stimulation; Dopamine Agonists; Dyskinesias; Dystonia; Humans; Levodopa; Muscle Rigidity; Parkinson Disease; Selegiline; Treatment Outcome; Tremor | 2008 |
Differentiating vascular parkinsonism from idiopathic Parkinson's disease: a systematic review.
Topics: Age Factors; Antiparkinson Agents; Brain; Cerebrovascular Disorders; Diagnosis, Differential; Dopamine Plasma Membrane Transport Proteins; Gait; Humans; Levodopa; Parkinson Disease; Parkinson Disease, Secondary; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon; Tremor | 2010 |
[Current treatment strategies for Parkinson's disease].
Topics: Aged; Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Apomorphine; Critical Care; Deep Brain Stimulation; Dementia; Depression; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Europe; Female; Humans; Infusion Pumps, Implantable; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Psychotic Disorders; Sleep Wake Disorders; Tremor | 2011 |
[Parkinson's disease: current standards in diagnostics and therapy].
Topics: Antidepressive Agents; Antiparkinson Agents; Deep Brain Stimulation; Disruptive, Impulse Control, and Conduct Disorders; Drug Implants; Gait Disorders, Neurologic; Humans; Levodopa; Parkinson Disease; Psychoses, Substance-Induced; Tremor | 2012 |
Tremor.
Topics: Acetates; Amines; Anticonvulsants; Antiparkinson Agents; Cyclohexanecarboxylic Acids; Diagnosis, Differential; Electromyography; Essential Tremor; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Levodopa; Motor Cortex; Muscle, Skeletal; Parkinson Disease; Posture; Primidone; Randomized Controlled Trials as Topic; Severity of Illness Index; Somatosensory Cortex; Topiramate; Tremor | 2003 |
[Diagnosis and therapy for patients with vascular parkinsonism].
Topics: Akinetic Mutism; Amantadine; Antiparkinson Agents; Cerebral Infarction; Dementia, Vascular; Diagnosis, Differential; Gait Disorders, Neurologic; Humans; Levodopa; Muscle Rigidity; Parkinson Disease, Secondary; Platelet Aggregation Inhibitors; Posture; Secondary Prevention; Tremor | 2003 |
Profile of families with parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2).
Topics: Antiparkinson Agents; Brain; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Dystonia; Humans; Levodopa; Magnetic Resonance Imaging; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Parkinsonian Disorders; Posture; Spinocerebellar Ataxias; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tremor | 2004 |
Pathophysiology of motor fluctuations in Parkinson's disease.
Topics: Adaptation, Physiological; Antiparkinson Agents; Basal Ganglia; Corpus Striatum; Cyclic AMP; Dyskinesia, Drug-Induced; Globus Pallidus; Humans; Hypokinesia; Levodopa; Muscle Rigidity; Neural Pathways; Parkinson Disease; Receptors, Neurotransmitter; Thalamus; Tremor | 2005 |
Parkinson's disease. Diagnosis and the initiation of therapy.
Topics: Antioxidants; Diagnosis, Differential; Dopamine Agonists; Humans; Hypokinesia; Indans; Levodopa; Muscle Rigidity; Nerve Degeneration; Neuroprotective Agents; Parkinson Disease; Parkinsonian Disorders; Selegiline; Tremor | 2005 |
Motor fluctuations in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Carbidopa; Deep Brain Stimulation; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Motor Activity; Neurosurgical Procedures; Parkinson Disease; Tremor | 2006 |
[Tremor].
Topics: Adrenergic beta-Antagonists; Anticonvulsants; Antiparkinson Agents; Botulinum Toxins; Cholinergic Agents; Diagnosis, Differential; Dopamine Agents; Drug Therapy, Combination; Humans; Levodopa; Magnetic Resonance Imaging; Parkinson Disease; Patient Compliance; Primidone; Propranolol; Radionuclide Imaging; Time Factors; Tremor | 2007 |
[Diagnosis and treatment of tremor in Parkinson's disease and essential tremor].
Topics: Adrenergic beta-Antagonists; Amantadine; Anticonvulsants; Antiparkinson Agents; Deep Brain Stimulation; Diagnosis, Differential; Disease Progression; Drug Therapy, Combination; Electroencephalography; Humans; Levodopa; Middle Aged; Parkinson Disease; Practice Guidelines as Topic; Primidone; Tremor | 2007 |
The use of clozapine in neurologic disorders.
Topics: Clinical Trials as Topic; Clozapine; Drug Administration Schedule; Humans; Levodopa; Nervous System Diseases; Neurocognitive Disorders; Parkinson Disease; Tremor | 1994 |
[Motor dysfunction in the aged--approach to involuntary movements].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Blepharospasm; Botulinum Toxins; Humans; Levodopa; Middle Aged; Parkinson Disease; Tremor | 1997 |
Diagnostic criteria for Parkinson disease.
Topics: Antiparkinson Agents; Diagnostic Imaging; Humans; Levodopa; Parkinson Disease; Posture; Probability; Tremor | 1999 |
[Details and indications of pallidotomy and thalamotomy for Parkinson's disease].
Topics: Dyskinesia, Drug-Induced; Globus Pallidus; Humans; Levodopa; Muscle Rigidity; Parkinson Disease; Stereotaxic Techniques; Thalamus; Tremor | 2000 |
[Deep brain stimulation(DBS) therapy for parkkinson,s disease].
Topics: Clinical Trials as Topic; Dyskinesia, Drug-Induced; Electric Stimulation Therapy; Globus Pallidus; Humans; Levodopa; Muscle Rigidity; Parkinson Disease; Subthalamic Nucleus; Tremor; Ventral Thalamic Nuclei | 2000 |
[Pharmacological treatment of parkinsonian tremor].
Topics: Adrenergic beta-Antagonists; Antiparkinson Agents; Cholinergic Antagonists; Dopamine Agonists; Histamine H1 Antagonists; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Tremor | 2000 |
Use of selective thalamotomy for various kinds of movement disorder, based on basic studies.
Topics: Antiparkinson Agents; Cerebral Hemorrhage; Chorea; Dyskinesia, Drug-Induced; Dyskinesias; Dystonia; Electrodes, Implanted; Electroencephalography; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Movement Disorders; Muscle Rigidity; Paresthesia; Parkinson Disease; Postoperative Complications; Stereotaxic Techniques; Surgery, Computer-Assisted; Thalamic Nuclei; Tomography, X-Ray Computed; Treatment Outcome; Tremor | 2000 |
Tremor and dopamine agonists.
Topics: Antiparkinson Agents; Diagnosis, Differential; Dopamine Agonists; Humans; Levodopa; Parkinson Disease; Tremor | 2002 |
[Considerations in the drug treatment of parkinsonism (author's transl)].
Topics: Amantadine; Apomorphine; Bromocriptine; Dopamine; Ergolines; Extrapyramidal Tracts; Female; Humans; Levodopa; Male; Monoamine Oxidase Inhibitors; Neurotransmitter Agents; Parkinson Disease; Phosphodiesterase Inhibitors; Piribedil; Tremor | 1978 |
[Therapy of tparkinson's disease. Clinical and pharmacological viewpoints].
Topics: Adrenergic beta-Antagonists; Amantadine; Bromocriptine; Histamine H1 Antagonists; Humans; Levodopa; Monoamine Oxidase Inhibitors; MSH Release-Inhibiting Hormone; Muscle Rigidity; Parasympatholytics; Parkinson Disease; Posture; Psychoses, Substance-Induced; Tremor | 1979 |
Monoamine precursors and analogues.
Topics: 5-Hydroxytryptophan; Animals; Biogenic Amines; Dihydroxyphenylalanine; Dopamine beta-Hydroxylase; Drug Interactions; Drug Synergism; Humans; Levodopa; Mice; Parkinson Disease; Rats; Receptors, Drug; Stimulation, Chemical; Tremor; Tryptophan; Tyrosine | 1975 |
Physiopathology of experimental Parkinsonism in the monkey.
Topics: Animals; Cerebellum; Corpus Striatum; Disease Models, Animal; Dopamine; Haplorhini; Levodopa; Motor Cortex; Movement Disorders; Muscle Rigidity; Neural Pathways; Olivary Nucleus; Parkinson Disease, Secondary; Red Nucleus; Substantia Nigra; Tremor | 1975 |
Monkeys with nigrostriatal lesions effects of monoaminergic drugs.
Topics: Amino Acids; Animals; Antiparkinson Agents; Apomorphine; Biogenic Amines; Carboxy-Lyases; Catechol O-Methyltransferase Inhibitors; Chlorocebus aethiops; Corpus Striatum; Drug Interactions; Haplorhini; Harmaline; Levodopa; Monoamine Oxidase Inhibitors; Movement Disorders; Substantia Nigra; Tremor | 1976 |
[Neuropsychological evaluation before and after thalamic stimulation in 9 patients with Parkinson disease].
Topics: Aged; Electric Stimulation Therapy; Humans; Levodopa; Middle Aged; Parkinson Disease; Psychophysiologic Disorders; Stereotaxic Techniques; Thalamic Nuclei; Thalamus; Tremor | 1992 |
Effect of tremorigenic agents on the cerebellum: a review of biochemical and electrophysiological data.
Topics: Alkaloids; Animals; Cats; Cerebellar Nuclei; Cerebellum; Cyclic GMP; Diazepam; Dopamine; Electroencephalography; gamma-Aminobutyric Acid; Harmaline; Harmine; Levodopa; Medulla Oblongata; Neural Pathways; Olivary Nucleus; Rabbits; Spinal Cord; Synaptic Transmission; Tremor | 1985 |
Nervous mechanisms involved in experimentally induced extrapyramidal disturbances.
Topics: Animals; Basal Ganglia Diseases; Benztropine; Brain; Cats; Caudate Nucleus; Cerebellar Nuclei; Chlorpromazine; Corpus Striatum; Disease Models, Animal; Dopamine; Haloperidol; Haplorhini; Humans; Levodopa; Movement Disorders; Olivary Nucleus; Parkinson Disease; Putamen; Rats; Red Nucleus; Substantia Nigra; Thalamic Nuclei; Tremor | 1974 |
Trials
44 trial(s) available for levodopa and Tremor
| Article | Year |
|---|---|
Levodopa Response in Patients With Early Parkinson Disease: Further Observations of the LEAP Study.
Topics: Aged; Antiparkinson Agents; Carbidopa; Double-Blind Method; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Tremor | 2023 |
Dopamine-responsive and dopamine-resistant resting tremor in Parkinson disease.
Topics: Accelerometry; Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Dopamine Agents; Double-Blind Method; Drug Resistance; Female; Follow-Up Studies; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Netherlands; Parkinson Disease; Treatment Outcome; Tremor | 2020 |
Mavoglurant (AFQ056) in combination with increased levodopa dosages in Parkinson's disease patients.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Early Termination of Clinical Trials; Excitatory Amino Acid Antagonists; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, Kainic Acid; Sample Size; Severity of Illness Index; Tremor | 2016 |
Two-year follow-up on the effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Cognition Disorders; Combined Modality Therapy; Deep Brain Stimulation; Drug Resistance; Female; Follow-Up Studies; Functional Laterality; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Postoperative Care; Posture; Preoperative Care; Severity of Illness Index; Subthalamic Nucleus; Surveys and Questionnaires; Time Factors; Tremor | 2009 |
Brain penetration effects of microelectrodes and DBS leads in STN or GPi.
Topics: Aged; Antiparkinson Agents; Combined Modality Therapy; Deep Brain Stimulation; Electrodes, Implanted; Female; Follow-Up Studies; Globus Pallidus; Humans; Hypokinesia; Levodopa; Male; Microelectrodes; Middle Aged; Movement; Muscle Rigidity; Neurosurgical Procedures; Parkinson Disease; Subthalamic Nucleus; Treatment Outcome; Tremor | 2009 |
[Effect of dopamine agonist pramipexole (mirapex) on tremor, affective disorders and quality of life in patients with Parkinson's disease].
Topics: Adult; Aged; Benzothiazoles; Dopamine Agonists; Female; Humans; Levodopa; Male; Middle Aged; Mood Disorders; Parkinson Disease; Pramipexole; Quality of Life; Tremor | 2010 |
Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Catechols; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Dysarthria; Facial Expression; Female; Humans; Hypokinesia; Indans; Levodopa; Male; Middle Aged; Monoamine Oxidase Inhibitors; Motor Activity; Muscle Rigidity; Nitriles; Parkinson Disease; Severity of Illness Index; Tremor | 2011 |
Unilateral caudal zona incerta deep brain stimulation for Parkinsonian tremor.
Topics: Aged; Antiparkinson Agents; Deep Brain Stimulation; Drug Resistance; Female; Follow-Up Studies; Functional Laterality; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Subthalamic Nucleus; Subthalamus; Treatment Outcome; Tremor | 2012 |
Subthalamotomy for advanced Parkinson disease.
Topics: Aged; Antiparkinson Agents; Dyskinesias; Female; Functional Laterality; Humans; Hypokinesia; Levodopa; Magnetic Resonance Imaging; Male; Microelectrodes; Middle Aged; Parkinson Disease; Postoperative Complications; Radiosurgery; Subthalamic Nucleus; Treatment Outcome; Tremor | 2002 |
[123I]-FP-CIT-SPECT demonstrates dopaminergic deficit in orthostatic tremor.
Topics: Aged; Aged, 80 and over; Dopamine; Dopamine Agents; Electromyography; Female; Humans; Iodine Radioisotopes; Levodopa; Male; Middle Aged; Smell; Tomography, Emission-Computed, Single-Photon; Tremor; Tropanes; Videotape Recording | 2003 |
Randomized trial of pallidotomy versus medical therapy for Parkinson's disease.
Topics: Antiparkinson Agents; Atrophy; Brain; Carbidopa; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Combinations; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Globus Pallidus; Humans; Hypokinesia; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Muscle Rigidity; Neurosurgical Procedures; Parkinson Disease; Severity of Illness Index; Treatment Outcome; Tremor | 2003 |
Further experience with extradural motor cortex stimulation for treatment of advanced Parkinson's disease. Report of 3 new cases.
Topics: Aged; Deglutition Disorders; Dura Mater; Dyskinesia, Drug-Induced; Electric Stimulation Therapy; Electrodes; Electrodes, Implanted; Female; Gait Disorders, Neurologic; Humans; Levodopa; Magnetic Resonance Imaging; Male; Motor Cortex; Muscle Rigidity; Parkinson Disease; Treatment Outcome; Tremor | 2003 |
Levodopa effect upon functional balance of Parkinson's disease patients.
Topics: Aged; Antiparkinson Agents; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Postural Balance; Posture; Tremor | 2004 |
Alpha-dihydroergocryptine in the long-term therapy of Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Dihydroergocryptine; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Muscle Rigidity; Parkinson Disease; Posture; Psychomotor Performance; Speech Disorders; Tremor | 2004 |
Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.
Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Deep Brain Stimulation; Female; Globus Pallidus; Humans; Hypokinesia; Intraoperative Complications; Levodopa; Male; Middle Aged; Parkinson Disease; Patient Selection; Pilot Projects; Postoperative Complications; Subthalamic Nucleus; Treatment Outcome; Tremor | 2005 |
Tremor reduction by subthalamic nucleus stimulation and medication in advanced Parkinson's disease.
Topics: Aged; Analysis of Variance; Antiparkinson Agents; Deep Brain Stimulation; Electromyography; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Prospective Studies; Psychiatric Status Rating Scales; Severity of Illness Index; Subthalamic Nucleus; Tremor | 2007 |
Effects of methylphenidate on response to oral levodopa: a double-blind clinical trial.
Topics: Administration, Oral; Aged; Antiparkinson Agents; Cross-Over Studies; Dopamine Uptake Inhibitors; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Methylphenidate; Middle Aged; Parkinson Disease; Psychomotor Performance; Severity of Illness Index; Time Perception; Tremor; Walking | 2007 |
Bromocriptine: low-dose therapy in Parkinson disease.
Topics: Aged; Bromocriptine; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos; Tremor | 1982 |
Effect of GPi pallidotomy on motor function in Parkinson's disease.
Topics: Activities of Daily Living; Adult; Aged; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Gait; Globus Pallidus; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Stereotaxic Techniques; Tremor; Videotape Recording | 1995 |
3H-spiperone binding to lymphocytes fails in the differential diagnosis of de novo Parkinson syndromes.
Topics: Adult; Aged; Butaclamol; Diagnosis, Differential; Double-Blind Method; Female; Humans; Kinetics; Levodopa; Lymphocytes; Male; Middle Aged; Parkinson Disease; Prospective Studies; Spiperone; Tremor | 1993 |
Effect of age and disease duration on parkinsonian motor scores under levodopa therapy.
Topics: Adult; Aged; Aging; Antiparkinson Agents; Bromocriptine; Disease Progression; Female; Gait; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Psychomotor Performance; Tremor | 1995 |
'Atypical' tremor.
Topics: Benserazide; Child; Child, Preschool; Cross-Over Studies; Double-Blind Method; Drug Combinations; Electromyography; Female; Humans; Infant; Levodopa; Male; Parkinson Disease; Propranolol; Tremor | 1995 |
Early-onset parkinsonism with dystonia. Clinical and biochemical differences from hereditary progressive dystonia or DOPA-responsive dystonia.
Topics: Adolescent; Adult; Age of Onset; Aged; Antiparkinson Agents; Biopterins; Child; Child, Preschool; Diagnosis, Differential; Dystonia; Female; Genetic Linkage; Humans; Levodopa; Male; Middle Aged; Neopterin; Parkinson Disease; Tremor | 1996 |
Does thalamotomy alter the course of Parkinson's disease?
Topics: Adult; Age of Onset; Aged; Antiparkinson Agents; Combined Modality Therapy; Disease Progression; Female; Follow-Up Studies; Functional Laterality; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Thalamus; Treatment Outcome; Tremor | 1996 |
Age at onset: the major determinant of outcome in Parkinson's disease.
Topics: Adult; Age of Onset; Aged; Antiparkinson Agents; Bromocriptine; Dose-Response Relationship, Drug; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Postural Balance; Treatment Outcome; Tremor | 1995 |
Tremor and voluntary repetitive movement in Parkinson's disease: comparison before and after L-dopa with positron emission tomography.
Topics: Aged; Antiparkinson Agents; Cerebrovascular Circulation; Hand; Humans; Levodopa; Magnetic Resonance Imaging; Middle Aged; Movement; Parkinson Disease; Rest; Tomography, Emission-Computed; Tremor | 1996 |
Postural tremor of Parkinson's disease.
Topics: Adult; Aged; Antiparkinson Agents; Benserazide; Electromyography; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Propranolol; Tremor | 1994 |
Levodopa may improve orthostatic tremor: case report and trial of treatment.
Topics: Aged; Electromyography; Female; Humans; Levodopa; Male; Middle Aged; Muscles; Posture; Tremor | 1999 |
Tremorlytic activity of budipine in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Double-Blind Method; Electromyography; Female; Humans; Levodopa; Male; Parkinson Disease; Piperidines; Tremor | 1999 |
A cross-over clinical and electromyographic assessment of treatment for parkinsonian tremor.
Topics: Aged; Antiparkinson Agents; Biperiden; Cross-Over Studies; Electromyography; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Posture; Tremor | 2001 |
CT-guided unilateral thalamotomy with macroelectrode mapping for the treatment of Parkinson's disease.
Topics: Activities of Daily Living; Adult; Aged; Antiparkinson Agents; Electrodes; Electrophysiology; Female; Humans; Levodopa; Male; Mental Health; Middle Aged; Morbidity; Parkinson Disease; Quality of Life; Radiography, Interventional; Severity of Illness Index; Stereotaxic Techniques; Thalamus; Tomography, X-Ray Computed; Treatment Outcome; Tremor | 2001 |
Subthalamic nucleus stimulation for Parkinson disease: benefits observed in levodopa-intolerant patients.
Topics: Adult; Aged; Antiparkinson Agents; Electric Stimulation Therapy; Female; Follow-Up Studies; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Severity of Illness Index; Subthalamic Nucleus; Time Factors; Treatment Outcome; Tremor | 2001 |
The effect of stage of Parkinson's disease at the onset of levodopa therapy on development of motor complications.
Topics: Age of Onset; Aged; Antiparkinson Agents; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Movement; Muscle Rigidity; Parkinson Disease; Sex Characteristics; Tremor | 2002 |
Ropinirole for the treatment of tremor in early Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Double-Blind Method; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Treatment Outcome; Tremor | 2002 |
Studies with bromocriptine. Part 2. Double-blind comparison with levodopa in idiopathic parkinsonism.
Topics: Aged; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Tremor | 1976 |
Clinical and pharmacological evaluation of the effects of piribedil in patients with parkinsonism.
Topics: Aged; Antiparkinson Agents; Chorea; Clinical Trials as Topic; Confusion; Dioxoles; Dopamine; Drug Evaluation; Electromyography; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Male; Middle Aged; Motor Skills; Muscle Rigidity; Nausea; Parkinson Disease; Parkinson Disease, Postencephalitic; Piperazines; Pyrimidines; Tremor | 1975 |
Indications of piribedil in L-DOPA-treated parkinsonian patients: physiopathologic implications.
Topics: Adult; Aged; Benserazide; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Levodopa; Male; Middle Aged; Muscle Tonus; Parkinson Disease; Piperazines; Piribedil; Reflex, Monosynaptic; Tremor | 1975 |
Amphetamines in the treatment of Parkinson's disease.
Topics: Aged; Amantadine; Amphetamine; Clinical Trials as Topic; Female; Humans; Isomerism; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Parkinson Disease, Postencephalitic; Posture; Structure-Activity Relationship; Tremor | 1975 |
[Polygraphic recording of tremor and of hypertonic phenomena. Application to the action of various drugs].
Topics: Antiparkinson Agents; Apomorphine; Clinical Trials as Topic; Dopa Decarboxylase; Drug Combinations; Drug Evaluation; Electrodiagnosis; Electromyography; Humans; Levodopa; Medical Records; Muscle Tonus; Oscillometry; Parkinson Disease; Piribedil; Tremor | 1975 |
Tremor in Parkinson disease: acute response to oral levodopa.
Topics: Administration, Oral; Diagnosis, Computer-Assisted; Humans; Levodopa; Parkinson Disease; Posture; Rest; Time Factors; Tremor | 1990 |
Multicenter trial of L-Deprenyl in Parkinson disease.
Topics: Adult; Affect; Aged; Clinical Trials as Topic; Disability Evaluation; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Phenethylamines; Selegiline; Tremor | 1986 |
Levodopa and monoamine oxidase inhibitor combination therapy. A controlled clinical trial.
Topics: Aged; Benserazide; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Monoamine Oxidase Inhibitors; Muscle Rigidity; Parkinson Disease; Parkinson Disease, Secondary; Tremor | 1987 |
Adjuvant therapy of parkinsonian tremor.
Topics: Aged; Antiparkinson Agents; Carbidopa; Clonazepam; Double-Blind Method; Drug Therapy, Combination; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Primidone; Propranolol; Random Allocation; Tremor; Trihexyphenidyl | 1987 |
[Levodopa as a single treatment of Parkinsonism. Long-term control of 24 cases with discrimination analysis].
Topics: Adult; Aged; Clinical Trials as Topic; Drug Evaluation; Female; Follow-Up Studies; Humans; Levodopa; Male; Methods; Middle Aged; Movement Disorders; Muscle Rigidity; Parkinson Disease; Pyramidal Tracts; Time Factors; Tremor | 1974 |
Other Studies
251 other study(ies) available for levodopa and Tremor
| Article | Year |
|---|---|
Focused Ultrasound Thalamotomy in Tremor Dominant Parkinson's Disease: Long-Term Results.
Topics: Aged; Essential Tremor; Humans; Levodopa; Middle Aged; Parkinson Disease; Thalamus; Treatment Outcome; Tremor | 2022 |
Autoimmune-mediated secondary-parkinsonism presented with micrographia and cognitive impairment.
Topics: Adult; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Antiparkinson Agents; Autoantibodies; Benserazide; Cognitive Dysfunction; Drug Combinations; Fever of Unknown Origin; Handwriting; Humans; Immunosuppressive Agents; Immunotherapy; Levodopa; Male; Methylprednisolone; Neuropsychological Tests; Parkinson Disease, Secondary; Tremor | 2021 |
How much time is needed in clinical practice to reach a diagnosis of clinically established Parkinson's disease?
Topics: Aged; Diagnosis, Differential; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Parkinsonian Disorders; Symptom Assessment; Time Factors; Tremor | 2021 |
A case of treatable encephalopathy, developmental regression, and proximal tremor.
Topics: Brain Diseases; Developmental Disabilities; Dystonic Disorders; Humans; Infant; Levodopa; Male; Treatment Outcome; Tremor | 2021 |
Cholinergic relevant functional reactivity is associated with dopamine responsiveness of tremor in Parkinson's disease.
Topics: Antiparkinson Agents; Cholinergic Agents; Dopamine; Humans; Levodopa; Magnetic Resonance Imaging; Parkinson Disease; Tremor | 2022 |
The Impact of Wearable Electronics in Assessing the Effectiveness of Levodopa Treatment in Parkinson's Disease.
Topics: Humans; Hypokinesia; Levodopa; Parkinson Disease; Tremor; Wearable Electronic Devices | 2022 |
Dissecting the Domains of Parkinson's Disease: Insights from Longitudinal Item Response Theory Modeling.
Topics: Bayes Theorem; Humans; Inosine; Levodopa; Parkinson Disease; Severity of Illness Index; Tremor; Uric Acid | 2022 |
Magnetic Resonance-Guided Focused Ultrasound Thalamotomy May Spare Dopaminergic Therapy in Early-Stage Tremor-Dominant Parkinson's Disease: A Pilot Study.
Topics: Essential Tremor; Humans; Levodopa; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Parkinson Disease; Pilot Projects; Thalamus; Treatment Outcome; Tremor | 2022 |
Neurodevelopmental disorder with dystonia due to SOX6 mutations.
Topics: Dystonia; Dystonic Disorders; Facial Asymmetry; Humans; Levodopa; Musculoskeletal Abnormalities; Mutation; Neurodevelopmental Disorders; SOXD Transcription Factors; Tremor | 2022 |
The Importance of Early Identification for Parkinson's Disease Patients with Postural Instability and Gait Disturbance.
Topics: Gait; Humans; Levodopa; Logistic Models; Parkinson Disease; Tremor | 2022 |
Sleep benefit in patients with Parkinson's disease is associated with the dopamine transporter expression in putamen.
Topics: Cocaine; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Humans; Levodopa; Parkinson Disease; Putamen; Sleep; Tremor | 2023 |
Long-term motor outcomes of deep brain stimulation of the globus pallidus interna in Parkinson's disease patients: Five-year follow-up.
Topics: Aged; Deep Brain Stimulation; Dyskinesias; Follow-Up Studies; Globus Pallidus; Humans; Levodopa; Middle Aged; Parkinson Disease; Retrospective Studies; Treatment Outcome; Tremor | 2023 |
Prognostic factors of unilateral prelemniscal radiations radiofrequency lesions: A surgical technique for the treatment of Parkinson's disease motor symptoms.
Topics: Child; Child, Preschool; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prognosis; Treatment Outcome; Tremor | 2023 |
Task Specific Tremor in Parkinson's Disease Responds to Apomorphine.
Topics: Apomorphine; Dopamine; Humans; Levodopa; Parkinson Disease; Tremor | 2023 |
Intravenous Magnesium Sulfate Reduces Tremor Severity: A Case Series.
Topics: Activities of Daily Living; Humans; Levodopa; Magnesium Sulfate; Parkinson Disease; Tremor | 2023 |
Cerebral differences between dopamine-resistant and dopamine-responsive Parkinson's tremor.
Topics: Aged; Basal Ganglia; Brain; Cerebellum; Dopamine; Dopamine Agents; Double-Blind Method; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Motor Cortex; Neural Pathways; Parkinson Disease; Thalamus; Tremor | 2019 |
Genetic deletion of GPR88 enhances the locomotor response to L-DOPA in experimental parkinsonism while counteracting the induction of dyskinesia.
Topics: Adrenergic Agents; Animals; Antiparkinson Agents; Cholinesterase Inhibitors; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Dyskinesia, Drug-Induced; GABAergic Neurons; Glutamic Acid; Levodopa; Locomotion; Male; Medial Forebrain Bundle; Mice; Mice, Knockout; Movement; Neuronal Plasticity; Oxidopamine; Parkinsonian Disorders; Receptors, G-Protein-Coupled; RNA, Messenger; Serotonin; Tacrine; Tremor | 2020 |
Which Scale Best Detects Treatment Response of Tremor in Parkinsonism?
Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Deep Brain Stimulation; Drug Combinations; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Outcome Assessment, Health Care; Parkinsonian Disorders; Sensitivity and Specificity; Severity of Illness Index; Tremor | 2020 |
Improving Automatic Tremor and Movement Motor Disorder Severity Assessment for Parkinson's Disease with Deep Joint Training.
Topics: Cohort Studies; Diagnosis, Computer-Assisted; Hand; Humans; Levodopa; Motor Disorders; Parkinson Disease; Severity of Illness Index; Tremor | 2019 |
Effects of Deep Brain Stimulation on Postural Control in Parkinson's Disease.
Topics: Aged; Deep Brain Stimulation; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Postural Balance; Tremor | 2020 |
Update on the diagnosis and management of Parkinson's disease.
Topics: Humans; Levodopa; Parkinson Disease; Quality of Life; Treatment Outcome; Tremor | 2020 |
Levodopa-responsive Holmes head titubation caused by midbrain cavernoma hemorrhage.
Topics: Hemangioma, Cavernous; Hemorrhage; Humans; Levodopa; Magnetic Resonance Imaging; Mesencephalon; Tremor | 2021 |
Predictors of Pharyngeal Dysphagia in Patients with Parkinson's Disease.
Topics: Age Factors; Aged; Antiparkinson Agents; Deglutition Disorders; Female; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Postural Balance; Risk; Severity of Illness Index; Tremor | 2020 |
Comparison of effectiveness of trihexyphenidyl and levodopa on motor symptoms in Parkinson's disease.
Topics: Antiparkinson Agents; Humans; Hypokinesia; Infant, Newborn; Levodopa; Parkinson Disease; Treatment Outcome; Tremor; Trihexyphenidyl | 2020 |
Effects of dopamine on reinforcement learning in Parkinson's disease depend on motor phenotype.
Topics: Aged; Antiparkinson Agents; Benserazide; Computer Simulation; Conditioning, Operant; Dopamine Agonists; Drug Combinations; Female; Humans; Learning; Levodopa; Male; Middle Aged; Motivation; Parkinson Disease; Phenotype; Punishment; Reward; Tremor | 2020 |
Pediatric autoimmune Parkinsonism and response to deep brain stimulation.
Topics: Adolescent; Child; Deep Brain Stimulation; Female; Globus Pallidus; Humans; Levodopa; Parkinsonian Disorders; Treatment Outcome; Tremor | 2022 |
Chronic asymmetric tremor and levodopa-responsive parkinsonism due to a vein of Galen aneurysmal malformation.
Topics: Antiparkinson Agents; Chronic Disease; Female; Humans; Levodopa; Middle Aged; Parkinsonian Disorders; Tremor; Vein of Galen Malformations | 2017 |
Degeneration of the corticofugal tract from the secondary motor area in a Parkinson's disease patient with limb-kinetic apraxia: A case report.
Topics: Anisotropy; Antiparkinson Agents; Benserazide; Diffusion Tensor Imaging; Drug Combinations; Female; Humans; Levodopa; Middle Aged; Motor Cortex; Muscle Rigidity; Muscular Atrophy, Spinal; Parkinson Disease; Positron-Emission Tomography; Tremor | 2017 |
Prelemniscal Lesion for Selective Improvement of Parkinson Disease Tremor.
Topics: Aged; Carbidopa; Drug Combinations; Humans; Levodopa; Male; Parkinson Disease; Treatment Outcome; Tremor; Ventral Thalamic Nuclei | 2018 |
The nature of postural tremor in Parkinson disease.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Benserazide; Cluster Analysis; Dopamine; Drug Combinations; Electromyography; Female; Humans; Levodopa; Male; Middle Aged; Muscle, Skeletal; Parkinson Disease; Posture; Prevalence; Rest; Tremor | 2018 |
Re-emergent tremor in Parkinson's disease: the effect of dopaminergic treatment.
Topics: Aged; Antiparkinson Agents; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Monoamine Oxidase Inhibitors; Parkinson Disease; Recurrence; Treatment Outcome; Tremor | 2018 |
Jaw tremor: a manifestation of vascular parkinsonism? - a case report.
Topics: Aged; Brain; Female; Humans; Levodopa; Parkinsonian Disorders; Tremor; Vascular Diseases | 2018 |
Head and trunk stability during gait before and after levodopa intake in Parkinson's disease subtypes.
Topics: Aged; Female; Gait; Head; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Postural Balance; Torso; Tremor | 2018 |
Levodopa-responsive truncal tremor in a patient with spinocerebellar ataxia type 3.
Topics: Adult; Dopamine Agents; Electromyography; Humans; Levodopa; Machado-Joseph Disease; Magnetic Resonance Imaging; Male; Middle Aged; Tomography, Emission-Computed, Single-Photon; Tremor; Video Recording | 2018 |
Latency of re-emergent tremor in Parkinson's disease is influenced by levodopa.
Topics: Accelerometry; Aged; Antiparkinson Agents; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Recurrence; Time Factors; Tremor | 2019 |
Fact-finding survey on diagnostic procedures and therapeutic interventions for parkinsonism accompanying dementia with Lewy bodies.
Topics: Adult; Antiparkinson Agents; Antipsychotic Agents; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Lewy Body Disease; Middle Aged; Muscle Rigidity; Neurologists; Parkinsonian Disorders; Physicians; Postural Balance; Psychiatry; Psychotropic Drugs; Tremor | 2019 |
The Use of Data from the Parkinson's KinetiGraph to Identify Potential Candidates for Device Assisted Therapies.
Topics: Aged; Algorithms; Deep Brain Stimulation; Dyskinesias; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Sensitivity and Specificity; Tremor | 2019 |
Choreo-athetosis in LRRK2 R1441C mutation: expanding the clinical phenotype.
Topics: Antiparkinson Agents; Athetosis; Benzothiazoles; Chorea; Female; Gait Disorders, Neurologic; Humans; Hypokinesia; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Levodopa; Magnetic Resonance Imaging; Middle Aged; Mutation; Neurologic Examination; Phenotype; Positron-Emission Tomography; Pramipexole; Protein Serine-Threonine Kinases; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Tremor | 2013 |
Objective motion sensor assessment highly correlated with scores of global levodopa-induced dyskinesia in Parkinson's disease.
Topics: Adult; Aged; Algorithms; Antiparkinson Agents; Biomechanical Phenomena; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Linear Models; Male; Middle Aged; Movement; Neurologic Examination; Parkinson Disease; Tremor; Wrist | 2013 |
Asymmetric postural tremor preceding DOPA-responsive Parkinsonism - the transition disease.
Topics: Aged; Brain; Disease Progression; Humans; Levodopa; Middle Aged; Parkinsonian Disorders; Posture; Prospective Studies; Tremor | 2014 |
L-DOPA disrupts adenosine A(2A)-cannabinoid CB(1)-dopamine D(2) receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: biochemical and behavioral studies.
Topics: Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Cannabinoid Receptor Antagonists; Cholinesterase Inhibitors; Corpus Striatum; Disease Models, Animal; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Functional Laterality; Levodopa; Male; Oxidopamine; Parkinsonian Disorders; Piperidines; Protein Binding; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor Cross-Talk; Rimonabant; Tacrine; Time Factors; Tremor | 2014 |
Acute morphine treatments alleviate tremor in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Hypokinesia; Levodopa; Macaca mulatta; Male; Morphine; Motor Activity; Parkinson Disease; Postural Balance; Tremor | 2014 |
Cortico-muscular coherence in advanced Parkinson's disease with deep brain stimulation.
Topics: Aged; Cerebral Cortex; Deep Brain Stimulation; Electromyography; Female; Humans; Levodopa; Magnetoencephalography; Male; Middle Aged; Muscle Rigidity; Muscle, Skeletal; Parkinson Disease; Subthalamic Nucleus; Tremor | 2015 |
A woman with functional tremor treated with L-DOPA for 14 years.
Topics: Antiparkinson Agents; Female; Humans; Levodopa; Middle Aged; Treatment Outcome; Tremor | 2014 |
Dopamine-responsive pattern in tremor patients.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Treatment Outcome; Tremor | 2014 |
Varying time-course of effects of high frequency stimulation of sub-regions of the globus pallidus in patients with parkinson's disease.
Topics: Aged; Antiparkinson Agents; Combined Modality Therapy; Deep Brain Stimulation; Dyskinesias; Female; Follow-Up Studies; Globus Pallidus; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Time Factors; Treatment Outcome; Tremor | 2015 |
[Local brain activity in different motor subtypes of Parkinson's disease with fMRI].
Topics: Cerebellum; Humans; Levodopa; Magnetic Resonance Imaging; Parkinson Disease; Tremor | 2015 |
[VALIDATION OF THE HUNGARIAN MDS-UPDRS: WHY DO WE NEED A NEW PARKINSON SCALE?].
Topics: Antiparkinson Agents; Cognition; Factor Analysis, Statistical; Humans; Hungary; Language; Levodopa; Movement Disorders; Observer Variation; Parkinson Disease; Reproducibility of Results; Severity of Illness Index; Surveys and Questionnaires; Translations; Tremor | 2014 |
Different patterns of spontaneous brain activity between tremor-dominant and postural instability/gait difficulty subtypes of Parkinson's disease: a resting-state fMRI study.
Topics: Adult; Aged; Antiparkinson Agents; Brain; Brain Mapping; Female; Gait Disorders, Neurologic; Gray Matter; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Neural Pathways; Organ Size; Parkinson Disease; Rest; Tremor | 2015 |
Understanding Parkinson Disease: A Complex and Multifaceted Illness.
Topics: Basal Ganglia; Dopaminergic Neurons; Humans; Levodopa; Nurse's Role; Parkinson Disease; Substantia Nigra; Tremor | 2015 |
Discrimination and Characterization of Parkinsonian Rest Tremors by Analyzing Long-Term Correlations and Multifractal Signatures.
Topics: Deep Brain Stimulation; Humans; Levodopa; Parkinson Disease; Signal Processing, Computer-Assisted; Support Vector Machine; Tremor | 2016 |
Holmes' tremor as a delayed complication of thalamic stroke.
Topics: Aged; Dopamine Agents; Humans; Levodopa; Magnetic Resonance Imaging; Male; Stroke; Thalamus; Tremor | 2016 |
Holmes tremor: Clinical description, lesion localization, and treatment in a series of 29 cases.
Topics: Adolescent; Adult; Aged; Cerebrovascular Disorders; Child; Female; Humans; Levodopa; Male; Mesencephalon; Middle Aged; Psychosurgery; Retrospective Studies; Thalamus; Treatment Outcome; Tremor; Young Adult | 2016 |
Tremor in progressive supranuclear palsy.
Topics: Aged; Carbidopa; Dopamine Agents; Female; Humans; Levodopa; Male; Middle Aged; Retrospective Studies; Supranuclear Palsy, Progressive; Tremor | 2016 |
Facial tremors in patients with and without parkinsonism.
Topics: Aged; Aged, 80 and over; Dopamine Agents; Face; Female; Humans; Levodopa; Male; Parkinsonian Disorders; Retrospective Studies; Sensitivity and Specificity; Tremor | 2016 |
Benefits of subthalamic stimulation for elderly parkinsonian patients aged 70 years or older.
Topics: Aged; Antiparkinson Agents; Deep Brain Stimulation; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease; Subthalamic Nucleus; Tremor | 2016 |
The patient's perspective: The effect of levodopa on Parkinson symptoms.
Topics: Accelerometry; Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Patient Satisfaction; Physician-Patient Relations; Treatment Outcome; Tremor | 2017 |
Re-emergent tremor in Parkinson's disease: Clinical and accelerometric properties.
Topics: Aged; Antiparkinson Agents; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Patient Positioning; Rest; Tremor | 2017 |
Cognitive Stress Reduces the Effect of Levodopa on Parkinson's Resting Tremor.
Topics: Accelerometry; Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Cognitive Behavioral Therapy; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Rest; Severity of Illness Index; Tremor | 2017 |
Long-term treatment of Parkinson's disease with levodopa and other adjunctive drugs.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Drug Administration Schedule; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Treatment Outcome; Tremor | 2018 |
Levodopa response differs in Parkinson's motor subtypes: A task-based effective connectivity study.
Topics: Aged; Antiparkinson Agents; Brain; Brain Mapping; Female; Humans; Image Processing, Computer-Assisted; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Neural Pathways; Oxygen; Parkinson Disease; Postural Balance; Psychomotor Performance; Sensation Disorders; Tremor | 2017 |
A 5-HT2A receptor inverse agonist, ACP-103, reduces tremor in a rat model and levodopa-induced dyskinesias in a monkey model.
Topics: Animals; Data Interpretation, Statistical; Dopamine Agents; Dyskinesia, Drug-Induced; Jaw; Levodopa; Macaca fascicularis; Male; MPTP Poisoning; Piperidines; Rats; Rats, Sprague-Dawley; Serotonin 5-HT2 Receptor Agonists; Serotonin Receptor Agonists; Tremor; Urea | 2008 |
Levodopa might affect metaiodobenzylguanidine myocardial accumulation.
Topics: 3-Iodobenzylguanidine; Adult; Dopamine Agents; Humans; Levodopa; Male; Myocardium; Tremor | 2008 |
[Can subthalamic nucleus stimulation reveal parkinsonian rest tremor?].
Topics: Adrenal Rest Tumor; Antiparkinson Agents; Deep Brain Stimulation; Female; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Neurosurgical Procedures; Parkinson Disease; Subthalamic Nucleus; Tremor | 2009 |
Levodopa affects functional brain networks in Parkinsonian resting tremor.
Topics: Antiparkinson Agents; Brain; Brain Mapping; Cerebellum; Electromyography; Female; Humans; Levodopa; Male; Middle Aged; Motor Cortex; Nerve Net; Parietal Lobe; Parkinsonian Disorders; Somatosensory Cortex; Thalamus; Tremor | 2009 |
Late onset dopa-responsive dystonia with tremor, gait freezing and behavioural disturbance and a normal dopamine transporter scan.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Diagnosis, Differential; Dopamine Agents; Drug Therapy, Combination; Dystonia; Female; Gait Disorders, Neurologic; Humans; Levodopa; Pramipexole; Tremor | 2008 |
Pseudo-orthostatic and resting leg tremor in a large Spanish family with homozygous truncating parkin mutation.
Topics: Adult; Age of Onset; Antiparkinson Agents; Codon, Nonsense; Consanguinity; DNA Mutational Analysis; Exons; Female; Genotype; Humans; Levodopa; Male; Parkinsonian Disorders; Pedigree; Spain; Tremor; Ubiquitin-Protein Ligases | 2009 |
Development of Holmes' tremor in a patient with Parkinson's disease following acute cerebellar infarction.
Topics: Acute Disease; Aged, 80 and over; Antiparkinson Agents; Cerebellum; Cerebral Infarction; Disease Progression; Female; Humans; Levodopa; Parkinson Disease; Severity of Illness Index; Tremor | 2009 |
Quantifying drug induced dyskinesia in Parkinson's disease patients using standardized videos.
Topics: Analysis of Variance; Antiparkinson Agents; Biomedical Engineering; Diagnosis, Computer-Assisted; Dyskinesia, Drug-Induced; Humans; Levodopa; Movement; Parkinson Disease; Tremor; Video Recording | 2008 |
Possible Parkinson's disease revealed by a pure head resting tremor.
Topics: Aged; Antiparkinson Agents; Corpus Striatum; Diagnosis, Differential; Electromyography; Female; Head Movements; Humans; Levodopa; Muscle, Skeletal; Parkinson Disease; Tomography, Emission-Computed, Single-Photon; Tremor | 2009 |
Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects.
Topics: Adult; Age Factors; Aged; Antiparkinson Agents; Cognition; Deep Brain Stimulation; Female; Follow-Up Studies; Humans; Levodopa; Linear Models; Male; Middle Aged; Parkinson Disease; Predictive Value of Tests; Prognosis; Sex Factors; Subthalamic Nucleus; Time Factors; Treatment Outcome; Tremor | 2009 |
Tremor following ischemic stroke of the posterior thalamus.
Topics: Carbidopa; Dopamine Agents; Female; Humans; Hypercholesterolemia; Hypertension; Levodopa; Magnetic Resonance Imaging; Middle Aged; Stroke; Thalamus; Tremor | 2010 |
Movement disorders ii: chorea, dystonia, myoclonus, and tremor.
Topics: Child; Chorea; Dopamine Agents; Dyskinesia, Drug-Induced; Dyskinesias; Dystonia; Humans; Levodopa; Lupus Erythematosus, Systemic; Myoclonus; Tremor | 2010 |
Clinical features associated with REM sleep behavior disorder symptoms in the early stages of Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Cognition Disorders; Diagnostic and Statistical Manual of Mental Disorders; Disability Evaluation; Disease Progression; Female; Hallucinations; Humans; Levodopa; Male; Movement; Parkinson Disease; Polysomnography; Prognosis; REM Sleep Behavior Disorder; Surveys and Questionnaires; Tremor | 2011 |
Delayed-onset parkinsonian tremor following a mesencephalic lesion.
Topics: Antiparkinson Agents; Carbidopa; Dopamine; Drug Combinations; Electromyography; Female; Humans; Levodopa; Magnetic Resonance Imaging; Mesencephalon; Middle Aged; Neurologic Examination; Parkinson Disease; Tegmentum Mesencephali; Tremor | 2011 |
Lack of motor symptoms progression in Parkinson's disease patients with long-term bilateral subthalamic deep brain stimulation.
Topics: Aged; Deep Brain Stimulation; Disease Progression; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Retrospective Studies; Subthalamic Nucleus; Treatment Outcome; Tremor | 2010 |
Nigrostriatal dysfunction in patients with amyotrophic lateral sclerosis and parkinsonism.
Topics: Aged; Amyotrophic Lateral Sclerosis; Antiparkinson Agents; Corpus Striatum; Fluorine Radioisotopes; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Parkinsonian Disorders; Positron-Emission Tomography; Presynaptic Terminals; Putamen; Radiopharmaceuticals; Substantia Nigra; Tremor; Tropanes | 2011 |
Analysis of differences between physiological and pathological tremor of human fingers.
Topics: Antiparkinson Agents; Benserazide; Drug Combinations; Electromyography; Fingers; Humans; Isometric Contraction; Levodopa; Middle Aged; Parkinson Disease; Tremor | 2010 |
Deep brain stimulation in benign tremulous parkinsonism.
Topics: Adult; Aged; Cohort Studies; Deep Brain Stimulation; Disease Progression; Drug Resistance; Essential Tremor; Female; Humans; Levodopa; Male; Middle Aged; Parkinsonian Disorders; Patient Selection; Retrospective Studies; Subthalamic Nucleus; Treatment Outcome; Tremor; Ventral Thalamic Nuclei | 2011 |
Resting tremor in Parkinson disease: a negative predictor of levodopa-induced dyskinesia.
Topics: Aged; Antiparkinson Agents; Cohort Studies; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Predictive Value of Tests; Risk Assessment; Risk Factors; Tremor | 2011 |
Clinical and neuroimaging characteristics in neurodegenerative overlap syndrome.
Topics: Aged; Aged, 80 and over; Functional Laterality; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Motor Neuron Disease; Parkinsonian Disorders; Positron-Emission Tomography; Tremor; Tropanes | 2013 |
Long-duration Parkinson's disease: role of lateralization of motor features.
Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Case-Control Studies; Dementia; Disease Progression; Female; Functional Laterality; Humans; Levodopa; Longevity; Male; Middle Aged; Parkinson Disease; REM Sleep Behavior Disorder; Tremor | 2013 |
Long-lasting effect of levodopa on holmes' tremor.
Topics: Adult; Antiparkinson Agents; Central Nervous System Cysts; Female; Headache; Humans; Levodopa; Magnetic Resonance Imaging; Tremor | 2012 |
History of exposure to dopaminergic medication does not affect motor cortex plasticity and excitability in Parkinson's disease.
Topics: Adult; Aged; Antiparkinson Agents; Data Interpretation, Statistical; Dopamine Agents; Electric Stimulation; Electromyography; Female; Hand; Humans; Levodopa; Male; Middle Aged; Motor Cortex; Muscle Contraction; Neuronal Plasticity; Parkinson Disease; Transcranial Magnetic Stimulation; Tremor | 2013 |
Potential reliability and validity of a modified version of the Unified Parkinson's Disease Rating Scale that could be administered remotely.
Topics: Antiparkinson Agents; Benzothiazoles; Humans; Levodopa; Parkinson Disease; Pramipexole; Randomized Controlled Trials as Topic; Reproducibility of Results; Severity of Illness Index; Telemedicine; Tremor | 2013 |
Cohort study of prevalence and phenomenology of tremor in dementia with Lewy bodies.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Comorbidity; Double-Blind Method; Female; Humans; Levodopa; Lewy Body Disease; Male; Middle Aged; Prevalence; Severity of Illness Index; Treatment Outcome; Tremor | 2013 |
Lesioning the thalamus for dyskinesia.
Topics: Antiparkinson Agents; Antipsychotic Agents; Dyskinesia, Drug-Induced; Dyskinesias; Electrocoagulation; Haloperidol; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Parkinsonian Disorders; Reoperation; Retrospective Studies; Schizophrenia; Stereotaxic Techniques; Sulpiride; Torticollis; Treatment Outcome; Tremor; Ventral Thalamic Nuclei | 2001 |
[Tremor characteristics in the norm and in the diagnosis and treatment of parkinsonism].
Topics: Adult; Basal Ganglia; Diagnosis, Differential; Female; Fingers; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychomotor Performance; Tremor | 2002 |
Neonatal dopa-responsive extrapyramidal syndrome in twins with recessive GTPCH deficiency.
Topics: Adolescent; Antiparkinson Agents; Basal Ganglia Diseases; Carbidopa; Dopamine Agents; Dystonia; Female; Follow-Up Studies; Genes, Recessive; GTP Cyclohydrolase; Homozygote; Humans; Infant, Newborn; Infant, Newborn, Diseases; Levodopa; Metabolism, Inborn Errors; Muscle Rigidity; Mutation; Reflex, Abnormal; Remission Induction; Treatment Outcome; Tremor | 2003 |
Reversal of parkinsonism following liver transplantation.
Topics: Acute Disease; Aged; Antiparkinson Agents; Carbidopa; Disease Progression; Gait Disorders, Neurologic; Humans; Immunosuppressive Agents; Levodopa; Liver Cirrhosis; Liver Transplantation; Male; Parkinsonian Disorders; Remission Induction; Treatment Outcome; Tremor | 2003 |
Rest tremor in rhesus monkeys with MPTP-induced parkinsonism.
Topics: Animals; Female; Levodopa; Macaca mulatta; Male; MPTP Poisoning; Parkinson Disease, Secondary; Tremor | 2003 |
Gaucher's disease with Parkinson's disease: clinical and pathological aspects.
Topics: Adult; Age of Onset; Aged; Anemia; Antiparkinson Agents; Disease Progression; DNA Mutational Analysis; Drug Resistance; Female; Gaucher Disease; Glucosylceramidase; Hepatomegaly; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Recombinant Proteins; Siblings; Splenomegaly; Thrombocytopenia; Tremor | 2003 |
Relationship between freezing of gait (FOG) and other features of Parkinson's: FOG is not correlated with bradykinesia.
Topics: Antiparkinson Agents; Gait Ataxia; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Motor Activity; Movement Disorders; Parkinson Disease; Postural Balance; Speech Disorders; Tremor | 2003 |
[Effect of zonisamide on resting tremor resistant to antiparkinsonian medication].
Topics: Aged; Aged, 80 and over; Anticonvulsants; Antiparkinson Agents; Humans; Isoxazoles; Levodopa; Male; Middle Aged; Parkinson Disease; Tremor; Zonisamide | 2003 |
[Action of different inhibitors of L-DOPA 5 HTP decarboxylase on insulin hypoglycemia in the rat].
Topics: 5-Hydroxytryptophan; Animals; Antihypertensive Agents; Antimetabolites; Cinnamates; Dopa Decarboxylase; Hydrazines; Hyperinsulinism; Hypoglycemia; Insulins; Levodopa; Rats; Seizures; Tremor | 1963 |
[ON THE CONTROL OF AKINESIA AND OTHER EXTRAPYRAMIDAL MOTOR DISORDERS WITH L-DOPA (L-DIHYDROXYPHENYLALANINE)].
Topics: Chorea; Dihydroxyphenylalanine; Electromyography; Extrapyramidal Tracts; Humans; Levodopa; Monoamine Oxidase Inhibitors; Movement Disorders; Neurosurgery; Neurosurgical Procedures; Parkinsonian Disorders; Stereotaxic Techniques; Torticollis; Tremor | 1964 |
Development of levodopa-induced dyskinesias in parkinsonian monkeys may depend upon rate of symptom onset and/or duration of symptoms.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Appetite; Behavior, Animal; Blinking; Dopamine Agents; Dyskinesia, Drug-Induced; Facial Expression; Feeding Behavior; Levodopa; Macaca fascicularis; Male; Motor Activity; Motor Skills; Parkinson Disease, Secondary; Postural Balance; Posture; Time Factors; Tremor | 2003 |
Parkinson's disease, subthalamic stimulation, and selection of candidates: a pathological study.
Topics: Aged; Antiparkinson Agents; Cognition Disorders; Disease Progression; Dyskinesia, Drug-Induced; Electric Stimulation Therapy; Fatal Outcome; Female; Humans; Levodopa; Neuropsychological Tests; Parkinson Disease; Subthalamic Nucleus; Tremor | 2003 |
SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzophenones; Brain; Corpus Striatum; Disease Models, Animal; Dopamine; Drug Interactions; Levodopa; Maze Learning; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Monoamine Oxidase Inhibitors; MPTP Poisoning; Nervous System Diseases; Nitrophenols; Oxazoles; Oxidopamine; Prefrontal Cortex; Quinolines; Rats; Rats, Sprague-Dawley; Serotonin; Stereotyped Behavior; Tolcapone; Tremor; Tyramine | 2004 |
Ten-Hertz stimulation of subthalamic nucleus deteriorates motor symptoms in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Dominance, Cerebral; Drug Therapy, Combination; Electric Conductivity; Electric Stimulation Therapy; Electrodes, Implanted; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Nerve Net; Neurologic Examination; Parkinson Disease; Stereotaxic Techniques; Subthalamic Nucleus; Surgery, Computer-Assisted; Treatment Failure; Tremor | 2004 |
Levodopa-responsive parkinsonism in hereditary spastic paraplegia with thin corpus callosum.
Topics: Adolescent; Antiparkinson Agents; Benztropine; Cognition Disorders; Corpus Callosum; Electroencephalography; Female; Gait Disorders, Neurologic; Humans; Levodopa; Magnetic Resonance Imaging; Male; Muscle Weakness; Neuropsychological Tests; Parkinson Disease; Selegiline; Spastic Paraplegia, Hereditary; Tremor | 2004 |
Effect of levodopa treatment for parkinsonism in welders: a double-blind study.
Topics: Age of Onset; Brain; Clinical Trials as Topic; Diagnosis, Differential; Diagnostic Errors; Dopamine Agents; Double-Blind Method; Dystonia; Gait Disorders, Neurologic; Humans; Levodopa; Manganese; Manganese Poisoning; Occupational Exposure; Parkinson Disease, Secondary; Tremor; Welding | 2004 |
Clinical features of LRRK2-associated Parkinson's disease in central Norway.
Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Antiparkinson Agents; Female; Heterozygote; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Levodopa; Male; Middle Aged; Muscle Rigidity; Mutation; Norway; Parkinson Disease; Pedigree; Protein Serine-Threonine Kinases; Tremor | 2005 |
Parkinsonian action tremor: interference with object manipulation and lacking levodopa response.
Topics: Adult; Aged; Dopamine Agents; Female; Hand; Hand Strength; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Motor Skills; Movement; Parkinson Disease; Tremor; Weight-Bearing | 2005 |
Throat clicking as the initial symptom of Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Diagnosis, Differential; Humans; Levodopa; Male; Myoclonus; Palate, Soft; Parkinson Disease; Tongue; Tremor; Voice | 2005 |
Effects of deep brain stimulation and medication on strength, bradykinesia, and electromyographic patterns of the ankle joint in Parkinson's disease.
Topics: Ankle Joint; Antiparkinson Agents; Biomechanical Phenomena; Carbidopa; Combined Modality Therapy; Deep Brain Stimulation; Electrodes, Implanted; Electromyography; Humans; Hypokinesia; Isometric Contraction; Levodopa; Muscle Weakness; Muscle, Skeletal; Parkinson Disease; Reference Values; Signal Processing, Computer-Assisted; Statistics as Topic; Torque; Treatment Outcome; Tremor | 2006 |
Ambulatory motor assessment in Parkinson's disease.
Topics: Activities of Daily Living; Adult; Aged; Algorithms; Antiparkinson Agents; Female; Humans; Hypokinesia; Levodopa; Male; Mathematical Computing; Middle Aged; Monitoring, Ambulatory; Neurologic Examination; Parkinson Disease; Reproducibility of Results; Signal Processing, Computer-Assisted; Tremor; Videotape Recording | 2006 |
Gender and the Parkinson's disease phenotype.
Topics: Activities of Daily Living; Age of Onset; Analysis of Variance; Antiparkinson Agents; Chi-Square Distribution; Cohort Studies; Databases, Factual; Depression; Female; Functional Laterality; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Male; Muscle Rigidity; Parkinson Disease; Phenotype; Retrospective Studies; Sex Factors; Time Factors; Tremor | 2005 |
Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation.
Topics: Adult; Age of Onset; Brain; Dopamine; Ethnicity; Female; Genetic Carrier Screening; Genetic Predisposition to Disease; Heterozygote; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Mutation; Parkinson Disease; Tremor; Ubiquitin-Protein Ligases | 2005 |
Progression of Parkinson's disease following thalamic deep brain stimulation for tremor.
Topics: Aged; Deep Brain Stimulation; Disease Progression; Follow-Up Studies; Gait; Humans; Hypokinesia; Levodopa; Middle Aged; Motor Skills; Muscle Rigidity; Parkinson Disease; Severity of Illness Index; Thalamus; Tremor; Verbal Behavior | 2005 |
Three in one: case report supporting different origins of essential and parkinsonian tremors.
Topics: Aged; Antiparkinson Agents; Antithyroid Agents; Combined Modality Therapy; Deep Brain Stimulation; Diagnosis, Differential; Essential Tremor; Female; Humans; Hyperthyroidism; Levodopa; Neurologic Examination; Parkinson Disease; Parkinsonian Disorders; Tremor; Ventral Thalamic Nuclei | 2006 |
Symptomatic treatment in the fragile X-associated tremor/ataxia syndrome.
Topics: Adrenergic beta-Antagonists; Aged; Anxiety Disorders; Benzodiazepines; Carbidopa; Central Nervous System Agents; Cerebellar Ataxia; Cholinesterase Inhibitors; Dopamine Agonists; Female; Fragile X Syndrome; Humans; Levodopa; Male; Memory Disorders; Middle Aged; Neurologic Examination; Parkinsonian Disorders; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Tremor | 2006 |
Levodopa can worsen tremor associated with dystonia.
Topics: Aged; Antiparkinson Agents; Carbidopa; Diagnostic Errors; Drug Combinations; Dystonia; Female; Humans; Levodopa; Neurologic Examination; Parkinsonian Disorders; Psychomotor Performance; Tremor | 2006 |
Effect of rivastigmine on tremor in patients with Parkinson's disease and dementia.
Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Cholinesterase Inhibitors; Dementia; Drug Therapy, Combination; Female; Functional Laterality; Humans; Levodopa; Male; Mental Status Schedule; Neurologic Examination; Neuroprotective Agents; Parkinson Disease; Phenylcarbamates; Rivastigmine; Tremor | 2006 |
Beta oscillatory activity in the subthalamic nucleus and its relation to dopaminergic response in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Beta Rhythm; Data Interpretation, Statistical; Dopamine; Dopamine Agents; Electrodes, Implanted; Electrophysiology; Evoked Potentials; Female; Fourier Analysis; Humans; Levodopa; Male; Microelectrodes; Middle Aged; Movement; Neurons; Parkinson Disease; Subthalamic Nucleus; Tremor | 2006 |
Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats.
Topics: Adenine; Adenosine A2 Receptor Antagonists; Adrenergic Agents; Animals; Antiparkinson Agents; Behavior, Animal; Corpus Striatum; Dynorphins; Enkephalins; Glutamate Decarboxylase; Isoenzymes; Levodopa; Male; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tacrine; Tremor; Triazoles | 2007 |
Bilateral subthalamotomy for advanced Parkinson disease.
Topics: Aged; Catheter Ablation; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Functional Laterality; Humans; Hypokinesia; Levodopa; Male; Microelectrodes; Middle Aged; Muscle Rigidity; Neural Pathways; Parkinson Disease; Radiosurgery; Subthalamic Nucleus; Time; Treatment Outcome; Tremor | 2007 |
Factors predicting response to dopaminergic treatment for resting tremor of Parkinson's disease.
Topics: Aged; Demography; Dopamine Agonists; Extremities; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Posture; Prospective Studies; Rest; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome; Tremor | 2008 |
Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.
Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Deep Brain Stimulation; Dyskinesias; Electrodes, Implanted; Female; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Posture; Psychoses, Substance-Induced; Retrospective Studies; Subthalamic Nucleus; Tremor | 2008 |
Deep brain stimulation of CM/PF of thalamus could be the new elective target for tremor in advanced Parkinson's Disease?
Topics: Adult; Antiparkinson Agents; Basal Ganglia Diseases; Deep Brain Stimulation; Electrodes, Implanted; Electromyography; Female; Humans; Intralaminar Thalamic Nuclei; Levodopa; Male; Middle Aged; Neurosurgical Procedures; Parkinson Disease; Tremor | 2008 |
The evolution of disability in Parkinson disease.
Topics: Activities of Daily Living; Aged; Diagnosis, Differential; Disabled Persons; Disease Progression; Female; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Self Care; Severity of Illness Index; Tremor | 2008 |
Provocation of Parkinsonian tremor.
Topics: Adult; Aged; Dopamine Agonists; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Tremor | 2008 |
Disruption of nigrostriatal and cerebellothalamic pathways in dopamine responsive Holmes' tremor.
Topics: Benzothiazoles; Cerebellum; Cerebral Hemorrhage; Diffusion Magnetic Resonance Imaging; Dopamine Agents; Female; Humans; Levodopa; Magnetic Resonance Imaging; Neostriatum; Neural Pathways; Pramipexole; Substantia Nigra; Syndrome; Thalamus; Tomography, Emission-Computed, Single-Photon; Tremor; Young Adult | 2009 |
Managing the patient with Parkinson's disease.
Topics: Activities of Daily Living; Antiparkinson Agents; Health Education; Histamine H1 Antagonists; Humans; Levodopa; Parkinson Disease; Self-Help Devices; Tremor | 1980 |
[Therapeutic concept in Parkinson disease].
Topics: Adrenergic beta-Antagonists; Amantadine; Antidepressive Agents, Tricyclic; Benzodiazepines; Bromocriptine; Depression; Fludrocortisone; Humans; Hypotension, Orthostatic; Levodopa; Midodrine; Parasympatholytics; Parkinson Disease; Physical Therapy Modalities; Thalamus; Tremor | 1983 |
The natural history of Parkinson's disease.
Topics: Activities of Daily Living; Dementia; Dysarthria; Gait; Humans; Levodopa; Movement Disorders; Muscle Rigidity; Parkinson Disease; Thalamus; Time Factors; Tremor | 1984 |
Electrophysiological studies with LON-954, a tremorogen, in the cat spinal cord.
Topics: Animals; Cats; Decerebrate State; Electrophysiology; Evoked Potentials; Female; Levodopa; Male; Reflex; Spinal Cord; Synapses; Tremor; Urea | 1984 |
Rubral tremor: clinical features and treatment of three cases.
Topics: Aged; Benztropine; Carbidopa; Cerebellum; Cerebrovascular Disorders; Female; Humans; Levodopa; Male; Middle Aged; Red Nucleus; Tegmentum Mesencephali; Thalamus; Tremor | 1984 |
Pharmacological basis of akinesia in Parkinson's disease.
Topics: Brain; Dopamine; Humans; Levodopa; Movement Disorders; Muscle Rigidity; Norepinephrine; Parkinson Disease; Receptors, Dopamine; Tremor | 1983 |
Potentiation by naloxone of the anti-oxotremorine effect of L-DOPA.
Topics: Animals; Carbidopa; Dose-Response Relationship, Drug; Drug Synergism; Levodopa; Male; Mice; Mice, Inbred ICR; Naloxone; Oxotremorine; Tremor | 1983 |
Diagnosis and management of Parkinson's disease.
Topics: Bromocriptine; Diagnosis, Differential; Humans; Levodopa; Muscle Rigidity; Parasympatholytics; Parkinson Disease; Tremor | 1984 |
Presynaptic neuron and postsynaptic dopamine receptor function in long term treatment of Parkinson's disease: a neuroendocrine study.
Topics: Aged; Apomorphine; Benserazide; Bromocriptine; Carbidopa; Female; Humans; Levodopa; Male; Middle Aged; Nomifensine; Parkinson Disease; Prolactin; Receptors, Dopamine; Selegiline; Tremor | 1980 |
Histidine-induced bizarre behaviour in rats: the possible involvement of central cholinergic system.
Topics: Animals; Atropine; Behavior, Animal; Dose-Response Relationship, Drug; Histamine; Histamine Antagonists; Histidine; Levodopa; Male; Motor Activity; Parasympathetic Nervous System; Rats; Rats, Inbred Strains; Tremor | 1982 |
Levodopa administration and multiple primary cutaneous melanomas.
Topics: Aged; Female; Humans; Levodopa; Melanoma; Neoplasms, Multiple Primary; Skin Neoplasms; Tremor | 1980 |
Suppression of "rubral" tremor with levodopa.
Topics: Brain Neoplasms; Hemangioma; Humans; Levodopa; Male; Mesencephalon; Middle Aged; Tremor | 1980 |
Suppression of "rubral" tremor with levodopa.
Topics: Humans; Levodopa; Tremor | 1980 |
New pathophysiology of Parkinson's disease revealed by posteroventral pallidotomy.
Topics: Combined Modality Therapy; Gait; Globus Pallidus; Humans; Levodopa; Movement Disorders; Parkinson Disease; Serotonin; Thalamus; Treatment Outcome; Tremor | 1995 |
Which factors predict cognitive decline in Parkinson's disease?
Topics: Activities of Daily Living; Age of Onset; Aged; Cognition Disorders; Depressive Disorder; Educational Status; Humans; Levodopa; Middle Aged; Movement Disorders; Neuropsychological Tests; Parkinson Disease; Prognosis; Severity of Illness Index; Task Performance and Analysis; Tremor | 1995 |
Role of selegiline as initial monotherapy in early Parkinson's disease.
Topics: Activities of Daily Living; Drug Tolerance; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Safety; Selegiline; Time Factors; Tremor | 1994 |
Anticholinergics and dyskinesia.
Topics: Aged; Biperiden; Carbidopa; Drug Combinations; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Neurologic Examination; Parkinson Disease; Tremor; Trihexyphenidyl | 1994 |
Zotepine reversibly induces akinesia and rigidity in Parkinson's disease patients with resting tremor or drug-induced psychosis.
Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Dibenzothiepins; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Muscle Rigidity; Neurologic Examination; Parkinson Disease; Psychoses, Substance-Induced; Tremor | 1994 |
Clinical features and natural history of multiple system atrophy. An analysis of 100 cases.
Topics: Adult; Aged; Brain Diseases; Cerebellar Diseases; Corpus Striatum; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Olivopontocerebellar Atrophies; Parkinson Disease; Substantia Nigra; Tremor | 1994 |
Rest tremor and extrapyramidal symptoms after midbrain haemorrhage: clinical and 18F-dopa PET evaluation.
Topics: Adult; Basal Ganglia Diseases; Dihydroxyphenylalanine; Electromyography; Fluorine Radioisotopes; Humans; Intracranial Arteriovenous Malformations; Levodopa; Male; Mesencephalon; Posture; Rest; Rupture, Spontaneous; Subarachnoid Hemorrhage; Thalamus; Tomography, Emission-Computed; Tremor | 1994 |
A quantitative study of levodopa-induced dyskinesia in Parkinson's disease.
Topics: Aged; Aged, 80 and over; Basal Ganglia; Dyskinesia, Drug-Induced; Humans; Levodopa; Male; Muscle Rigidity; Parkinson Disease; Tremor | 1993 |
The influence of the type, duration, severity and levodopa treatment of Parkinson's disease on cardiovascular autonomic responses.
Topics: Adult; Aged; Cardiovascular System; Female; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Severity of Illness Index; Tremor | 1993 |
Circadian secretion pattern of melatonin in de novo parkinsonian patients: evidence for phase-shifting properties of l-dopa.
Topics: Aged; Circadian Rhythm; Female; Humans; Levodopa; Male; Melatonin; Middle Aged; Movement Disorders; Muscle Rigidity; Parkinson Disease; Radioimmunoassay; Tremor | 1993 |
Early detection of L-dopa response in parkinsonian patients with a standardized tracking test.
Topics: Adult; Basal Ganglia; Benserazide; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Movement Disorders; Muscle Rigidity; Neurologic Examination; Orientation; Parkinson Disease; Psychomotor Performance; Signal Processing, Computer-Assisted; Tremor | 1993 |
Value and appropriate use of rating scales and apparative measurements in quantification of disability in Parkinson's disease.
Topics: Aged; Dementia; Depression; Depressive Disorder; Disability Evaluation; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Parkinson Disease; Psychomotor Performance; Reference Values; Tremor | 1993 |
Chronic thalamic stimulation improves tremor and levodopa induced dyskinesias in Parkinson's disease.
Topics: Aged; Combined Modality Therapy; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Electric Stimulation Therapy; Electromyography; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Prostheses and Implants; Thalamic Nuclei; Tremor | 1993 |
Is parkinsonian arm tremor a resting tremor?
Topics: Aged; Aged, 80 and over; Female; Fourier Analysis; Humans; Levodopa; Male; Microcomputers; Middle Aged; Muscle Contraction; Muscle Relaxation; Parkinson Disease; Posture; Signal Processing, Computer-Assisted; Tremor | 1993 |
Response to L-DOPA in multiple system atrophy.
Topics: Adult; Aged; Carbidopa; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Movement; Movement Disorders; Muscle Rigidity; Olivopontocerebellar Atrophies; Parkinson Disease; Tremor | 1993 |
S-adenosyl-L-methionine decreases motor activity in the rat: similarity to Parkinson's disease-like symptoms.
Topics: Animals; Behavior, Animal; Catecholamines; Immobilization; Levodopa; Male; Movement Disorders; Parkinson Disease; Rats; Rats, Sprague-Dawley; S-Adenosylmethionine; Tremor | 1993 |
Worsening of postural tremor in patients with levodopa-induced dyskinesia: a quantitative analysis.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Drug Combinations; Dyskinesia, Drug-Induced; Humans; Levodopa; Male; Middle Aged; Posture; Tremor | 1993 |
Levodopa reduces muscle tone and lower extremity tremor in Parkinson's disease.
Topics: Aged; Electromyography; Female; Humans; Levodopa; Male; Middle Aged; Muscle Tonus; Parkinson Disease; Tremor | 1995 |
Inclusion body myositis associated with a severe unilateral levodopa-responsive upper extremity tremor.
Topics: Action Potentials; Anti-Dyskinesia Agents; Brain Neoplasms; Electromyography; Hand; Humans; Inclusion Bodies; Levodopa; Lipoma; Magnetic Resonance Imaging; Male; Microscopy, Electron; Middle Aged; Muscle, Skeletal; Myositis, Inclusion Body; Propranolol; Tremor; Trihexyphenidyl; Vacuoles | 1996 |
Levodopa does not aggravate postural tremor in Parkinson's disease.
Topics: Aged; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Posture; Tremor | 1995 |
Parkinsonian rigidity, dopa-induced dyskinesia and chorea--dynamic studies on the basal ganglia-thalamocortical motor circuit using PET scan and depth microrecording.
Topics: Antiparkinson Agents; Basal Ganglia; Blood Glucose; Brain; Brain Mapping; Cerebral Cortex; Chorea; Deoxyglucose; Dyskinesia, Drug-Induced; Electrodes, Implanted; Energy Metabolism; Fluorodeoxyglucose F18; Globus Pallidus; Humans; Levodopa; Motor Neurons; Neural Pathways; Neurologic Examination; Parkinson Disease; Stereotaxic Techniques; Thalamic Nuclei; Tomography, Emission-Computed; Tremor | 1995 |
Striatal dopamine depletion, tremors, and hypokinesia following the intracranial injection of S-adenosylmethionine: a possible role of hypermethylation in parkinsonism.
Topics: Animals; Antiparkinson Agents; Caudate Nucleus; Dopamine; Dose-Response Relationship, Drug; Hypokinesia; Injections, Intraventricular; Levodopa; Male; Methylation; Motor Activity; Neostriatum; Parkinson Disease; Rats; Rats, Sprague-Dawley; S-Adenosylhomocysteine; S-Adenosylmethionine; Tremor | 1995 |
Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson's disease.
Topics: Aged; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Myoclonus; Parkinson Disease; Prospective Studies; Retrospective Studies; Tremor | 1997 |
Anti-tremor activity of talipexole produced by selective dopamine D2 receptor stimulation in cynomolgus monkeys with unilateral lesions in the ventromedial tegmentum.
Topics: Administration, Oral; Adrenergic alpha-Agonists; Animals; Azepines; Behavior, Animal; Bromocriptine; Dopamine Agents; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Hypnotics and Sedatives; Injections, Subcutaneous; Levodopa; Macaca fascicularis; Male; Receptors, Dopamine D2; Tegmentum Mesencephali; Tremor | 1997 |
Usefulness of pallidotomy in advanced Parkinson's disease.
Topics: Adult; Aged; Analysis of Variance; Female; Follow-Up Studies; Globus Pallidus; Humans; Intraoperative Complications; Levodopa; Lifting; Male; Middle Aged; Movement; Movement Disorders; Parkinson Disease; Pilot Projects; Prospective Studies; Reoperation; Statistics, Nonparametric; Tomography, X-Ray Computed; Treatment Outcome; Tremor; Video Recording | 1997 |
Midbrain tremor and hypertrophic olivary degeneration after pontine hemorrhage.
Topics: Adrenergic beta-Antagonists; Anticonvulsants; Antiparkinson Agents; Cerebral Hemorrhage; Clonazepam; Electric Stimulation; Electrodes, Implanted; Humans; Hypertrophy; Levodopa; Magnetic Resonance Imaging; Male; Mesencephalon; Middle Aged; Nerve Degeneration; Neural Pathways; Olivary Nucleus; Pons; Propranolol; Thalamus; Tremor | 1997 |
High prevalence of Parkinson's disease in the Faroe Islands.
Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Denmark; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Prevalence; Tremor | 1997 |
High-frequency stimulation of the globus pallidus internalis in Parkinson's disease: a study of seven cases.
Topics: Adult; Disease Progression; Dyskinesia, Drug-Induced; Electric Stimulation Therapy; Electrodes, Implanted; Follow-Up Studies; Gait; Globus Pallidus; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Movement Disorders; Muscle Rigidity; Parkinson Disease; Speech Disorders; Stereotaxic Techniques; Thalamic Nuclei; Treatment Outcome; Tremor | 1997 |
[A comparative study of the effect of bromocriptine and pergolide on Parkinson disease].
Topics: Aged; Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Muscle Rigidity; Parkinson Disease; Pergolide; Retrospective Studies; Tremor | 1997 |
Is levodopa toxic to human substantia nigra?
Topics: Adult; Aged; Aged, 80 and over; Child; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Substantia Nigra; Time Factors; Tomography, Emission-Computed; Tremor | 1997 |
A novel mutation of the GTP-cyclohydrolase I gene in a patient with hereditary progressive dystonia/dopa-responsive dystonia.
Topics: Adult; Circadian Rhythm; Dystonia; Electromyography; Female; GTP Cyclohydrolase; Humans; Levodopa; Lysine; Muscle, Skeletal; Point Mutation; Polymerase Chain Reaction; Threonine; Torticollis; Tremor | 1998 |
Orthostatic tremor: an electrophysiological analysis.
Topics: Aged; Antiparkinson Agents; Carbidopa; Central Nervous System Diseases; Clonazepam; Drug Combinations; Electroencephalography; Electromyography; Evoked Potentials; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Motor Neurons; Muscle, Skeletal; Neural Conduction; Posture; Treatment Outcome; Tremor | 1998 |
Gamma knife radiosurgery as a lesioning technique in movement disorder surgery.
Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Dopamine Agents; Dyskinesia, Drug-Induced; Electroencephalography; Female; Follow-Up Studies; Gait; Globus Pallidus; Hemianopsia; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Motor Skills; Movement Disorders; Muscle Rigidity; Neuropsychological Tests; Parkinson Disease; Radiosurgery; Radiotherapy Dosage; Safety; Single-Blind Method; Thalamus; Tremor | 1998 |
Pallidotomy revisited. Analysis of posteroventral pallidotomy.
Topics: Aged; Dyskinesia, Drug-Induced; Globus Pallidus; Humans; Levodopa; MMPI; Movement Disorders; Muscle Rigidity; Parkinson Disease; Postoperative Period; Stereotaxic Techniques; Thalamic Nuclei; Thalamus; Treatment Outcome; Tremor | 1997 |
A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor.
Topics: Chromosome Mapping; Chromosomes, Human, Pair 4; Female; Genes, Dominant; Haplotypes; Humans; Levodopa; Lod Score; Male; Parkinson Disease; Pedigree; Phenotype; Posture; Tremor | 1999 |
Exogenous levodopa is not toxic to elderly subjects with non-parkinsonian movement disorders: further clinical evidence.
Topics: Aged; Aged, 80 and over; Diagnostic Errors; Female; Humans; Levodopa; Parkinson Disease; Tremor | 1999 |
Objective assessment in Parkinson's disease: optoelectronic movement and force analysis in clinical routine and research.
Topics: Aging; Antiparkinson Agents; Dopamine Agonists; Electronics; Hand; Hand Strength; Humans; Levodopa; Methods; Movement; Optics and Photonics; Parkinson Disease; Posture; Reference Values; Tremor | 1999 |
Glottographic measures before and after levodopa treatment in Parkinson's disease.
Topics: Aged; Aged, 80 and over; Algorithms; Antiparkinson Agents; Electric Stimulation; Electronic Data Processing; Female; Glottis; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Software; Speech Acoustics; Speech Production Measurement; Tremor; Voice Disorders | 1999 |
Evaluation of a ginkgo biloba extract (EGb 761) in functional tests for monoamine oxidase inhibition.
Topics: 5-Hydroxytryptophan; Animals; Behavior, Animal; Dopamine Agents; Dose-Response Relationship, Drug; Drug Synergism; Flavonoids; Ginkgo biloba; Levodopa; Male; Mice; Monoamine Oxidase Inhibitors; Phenethylamines; Plant Extracts; Plants, Medicinal; Stereotyped Behavior; Tremor; Tryptamines | 2000 |
Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance.
Topics: Aged; Antiparkinson Agents; Dyskinesia, Drug-Induced; Electric Stimulation Therapy; Electrodes, Implanted; Electroencephalography; Female; Follow-Up Studies; Humans; Levodopa; Magnetic Resonance Imaging; Male; Mesencephalon; Middle Aged; Monitoring, Intraoperative; Movement; Parkinson Disease; Patient Care Planning; Radiology, Interventional; Red Nucleus; Safety; Stereotaxic Techniques; Subthalamic Nucleus; Tremor | 2000 |
Levodopa prolongs life expectancy and is non-toxic to substantia nigra.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Cadaver; Child; Disease Progression; Dystonia; Female; Humans; Levodopa; Longevity; Male; Middle Aged; Parkinsonian Disorders; Retrospective Studies; Substantia Nigra; Survival Analysis; Tremor | 2001 |
Clinical correlates of action tremor in Parkinson disease.
Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Antiparkinson Agents; Arm; Female; Humans; Hypokinesia; Levodopa; Male; Mental Status Schedule; Middle Aged; Motor Activity; Movement; Muscle Rigidity; Parkinson Disease; Physical Examination; Posture; Rest; Tremor; Video Recording | 2001 |
Post-stroke violent adventitial movement responsive to levo-dopa/carbi-dopa therapy.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Basal Ganglia; Carbidopa; Drug Therapy, Combination; Female; Humans; Levodopa; Movement Disorders; Stroke; Treatment Outcome; Tremor | 2001 |
Phenotypic characterisation of autosomal recessive PARK6-linked parkinsonism in three unrelated Italian families.
Topics: Adult; Age of Onset; Aged; Chromosomes, Human, Pair 1; Diagnosis, Differential; Disease Progression; Dyskinesia, Drug-Induced; Female; Functional Laterality; Gait Disorders, Neurologic; Genes, Recessive; Haplotypes; Humans; Italy; Levodopa; Lod Score; Male; Middle Aged; Parkinsonian Disorders; Pedigree; Phenotype; Syndrome; Tremor; Videotape Recording | 2001 |
Fast orthostatic tremor in Parkinson's disease mimicking primary orthostatic tremor.
Topics: Aged; Anti-Anxiety Agents; Antiparkinson Agents; Clonazepam; Electromyography; Female; Humans; Leg; Levodopa; Male; Parkinson Disease; Treatment Outcome; Tremor | 2001 |
Life-threatening parkinsonism induced by kava-kava.
Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Humans; Kava; Levodopa; Middle Aged; Parkinsonian Disorders; Tremor | 2002 |
Tyrosine hydroxylase deficiency: clinical manifestations of catecholamine insufficiency in infancy.
Topics: Consanguinity; Developmental Disabilities; Dopamine; Female; Follow-Up Studies; Humans; Infant; Levodopa; Neurologic Examination; Norepinephrine; Parkinsonian Disorders; Tremor; Tyrosine 3-Monooxygenase | 2002 |
Holmes' tremor following midbrain Toxoplasma abscess: clinical features and treatment of a case.
Topics: Antiparkinson Agents; Drug Therapy, Combination; Humans; Isoniazid; Levodopa; Magnetic Resonance Imaging; Male; Mesencephalon; Middle Aged; Tomography, X-Ray Computed; Toxoplasmosis, Cerebral; Tremor | 2002 |
Physiological and pharmacological aids in the differential diagnosis of tremor.
Topics: Ataxia; Diagnosis, Differential; Ethanol; Humans; Isoproterenol; Levodopa; Methods; Parkinson Disease; Phenothiazines; Polyneuropathies; Propranolol; Tremor | 1976 |
Dopaminephilic properties of ergot alkaloids.
Topics: Acetonitriles; Animals; Bromocriptine; Corpus Striatum; Ergolines; Ergot Alkaloids; Haplorhini; Humans; Levodopa; Parkinson Disease; Receptors, Dopamine; Spiperone; Substantia Nigra; Synaptosomes; Tremor; Tyrosine 3-Monooxygenase | 1978 |
Tremor induced by S-adenosyl-L-methionine: possible relation to L-dopa effects.
Topics: Animals; Brain Chemistry; Injections, Intraventricular; Levodopa; Mice; Mice, Inbred ICR; S-Adenosylmethionine; Tremor | 1978 |
Therapeutics of disordered movement.
Topics: Carbidopa; Chorea; Drug Administration Schedule; Dyskinesia, Drug-Induced; Dystonia Musculorum Deformans; Hepatolenticular Degeneration; Humans; Huntington Disease; Levodopa; Movement Disorders; Parasympatholytics; Parkinson Disease; Receptors, Cholinergic; Receptors, Dopamine; Tremor | 1977 |
Cataleptic effect of 61-91 beta-lipotropic hormone in rat.
Topics: 5-Hydroxytryptophan; Animals; beta-Lipotropin; Catalepsy; Catatonia; Dose-Response Relationship, Drug; Humans; Levodopa; Naloxone; Rats; Sheep; Tremor | 1977 |
Combination therapy of extrapyramidal disease with trihexyphenidyl and L-dopa: an electromyographic study with specific reference to tremor.
Topics: Aged; Basal Ganglia Diseases; Drug Therapy, Combination; Electromyography; Female; Humans; Levodopa; Middle Aged; Parkinson Disease; Torticollis; Tremor; Trihexyphenidyl | 1979 |
[Abnormal movements induced by psychotropic drugs].
Topics: Chorea; Dyskinesia, Drug-Induced; Humans; Levodopa; Lithium; Movement Disorders; Parkinson Disease, Secondary; Psychotropic Drugs; Receptors, Dopamine; Receptors, Drug; Tremor | 1979 |
[Neurochemical aspects of Parkinson tremor].
Topics: Antiparkinson Agents; gamma-Aminobutyric Acid; Histamine; Humans; Levodopa; Parkinson Disease, Secondary; Serotonin; Tremor | 1979 |
Role of the caudate nucleus in production of dyskinesia [proceedings].
Topics: Animals; Apomorphine; Cats; Caudate Nucleus; Dopamine; Dyskinesia, Drug-Induced; Electric Stimulation; Levodopa; Movement Disorders; Neural Pathways; Substantia Nigra; Tremor | 1979 |
An analysis of tremor--alteration of parkinsonian tremor by L-dopa and surgical treatment.
Topics: Electromyography; Female; Humans; Levodopa; Male; Parkinson Disease; Thalamus; Tremor | 1979 |
Abolition of oxotremorine effects by L-DOPA pretreatment.
Topics: Animals; Catalepsy; Diarrhea; Dose-Response Relationship, Drug; Drug Interactions; Humans; Levodopa; Male; Mice; Oxotremorine; Tears; Tremor | 1979 |
The pharmacology of N-carbamoyl-2-(2,6-dichlorophenyl)acetamidine hydrochloride (LON-954) a new tremorogenic agent.
Topics: Analgesics; Animals; Cats; Decerebrate State; Dogs; Drug Interactions; Drug Tolerance; Female; Levodopa; Male; Mice; Oxotremorine; Rabbits; Rats; Species Specificity; Spinal Cord; Time Factors; Tremor; Urea | 1977 |
[Long-term prognostic factors in Parkinson's disease (author's transl)].
Topics: Age Factors; Aged; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prognosis; Sex Factors; Time Factors; Tremor | 1978 |
Parkinson's disease improvement after the addition of levodopa-carbidopa to anticholinergic treatment. An open controlled study.
Topics: Administration, Oral; Adult; Aged; Carbidopa; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease, Secondary; Tremor; Trihexyphenidyl | 1978 |
[Stereotaxic surgery of tremors].
Topics: Humans; Levodopa; Neurosurgery; Parkinson Disease; Stereotaxic Techniques; Tremor | 1976 |
Stereotaxic lesions and movement disorders in monkeys.
Topics: Animals; Brain; Brain Mapping; Butyrophenones; Catalepsy; Catatonia; Cerebellum; Chorea; Haplorhini; Humans; Hypothalamus, Posterior; Levodopa; Mesencephalon; Methyltyrosines; Monoamine Oxidase Inhibitors; Motor Cortex; Movement Disorders; Parasympatholytics; Phenothiazines; Pons; Reserpine; Stereotaxic Techniques; Substantia Nigra; Tremor | 1975 |
Parkinsonism: animal analogues of the human disorder.
Topics: Animals; Butyrophenones; Chlorpromazine; Disease Models, Animal; Haplorhini; Hydroxydopamines; Levodopa; Methyltyrosines; Mice; Parkinson Disease; Rats; Reserpine; Substantia Nigra; Tremor | 1976 |
[Effects of simultaneous administration of pyridoxine in the combined administration of L-dopa and peripheral decarboxylase inhibitors. Experimental and clinical studies].
Topics: Animals; Carbidopa; Carboxy-Lyases; Dogs; Drug Therapy, Combination; Female; Haplorhini; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pyridoxine; Rats; Tremor | 1976 |
Influence of diazepam, L-DOPA and dopamine on the cerebellar and spinal electrical patterns induced by harmine in the rabbit.
Topics: Alkaloids; Animals; Cerebellum; Diazepam; Dopamine; Electroencephalography; Female; Harmine; Levodopa; Male; Rabbits; Spinal Cord; Time Factors; Tremor | 1977 |
The shaking patient. Diagnosis and management of tremor.
Topics: Amantadine; Carbidopa; Cerebellar Diseases; Humans; Levodopa; Parkinson Disease; Propranolol; Tremor | 1977 |
Urinary monoamine metabolite excretion in disorders of movement. Effects of amantadine and levodopa.
Topics: Amantadine; Chorea; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Methylhistamines; Middle Aged; Movement Disorders; Parkinson Disease; Phenylacetates; Tremor | 1977 |
Hereditary progressive dystonia with marked diurnal fluctuation.
Topics: Adolescent; Adult; Child; Circadian Rhythm; Dystonia Musculorum Deformans; Electroencephalography; Female; Humans; Levodopa; Middle Aged; Muscle Contraction; Muscle Rigidity; Muscles; Neural Conduction; Pedigree; Posture; Reflex, Monosynaptic; Sleep; Tremor | 1976 |
[A case of mental change resulting from L-dopa treatment].
Topics: Aged; Diagnostic Errors; Humans; Levodopa; Male; Parkinson Disease; Psychoses, Substance-Induced; Tremor | 1976 |
Treatment of parkinsonism with l-dopa and a decarboxylase inhibitor. An electrophysiological and clinical study.
Topics: Aged; Carboxy-Lyases; Drug Combinations; Drug Evaluation; Electrophysiology; Female; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Muscle Tonus; Parkinson Disease; Tremor | 1975 |
Motor unit control in Parkinson's disease and the influence of levodopa.
Topics: Aged; Humans; Levodopa; Motor Neurons; Muscle Contraction; Parkinson Disease; Physical Exertion; Tremor | 1975 |
[Slow leg tremor].
Topics: Adult; Aged; Alcoholism; Follow-Up Studies; Humans; Leg; Levodopa; Male; Middle Aged; Propranolol; Tremor | 1975 |
[The deterioration of patients with parkinsonism treated with L-dopa].
Topics: Aged; Cognition Disorders; Follow-Up Studies; Humans; Levodopa; Middle Aged; Movement Disorders; Muscle Tonus; Parkinson Disease; Postural Balance; Recurrence; Tremor | 1975 |
Diseases of the central nervous system. Involuntary movements.
Topics: Athetosis; Central Nervous System Diseases; Chorea; Face; Humans; Levodopa; Movement Disorders; Myoclonus; Parkinson Disease; Spasm; Tic Disorders; Torticollis; Tremor | 1975 |
Letter: Effect of levodopa on Parkinsonian tremor.
Topics: Humans; Levodopa; Parkinson Disease; Tremor | 1976 |
The importance of 5-hydroxytryptamine for the induction of harmine tremor and its antagonism by dopaminergic agonists assessed by lesions of the midbrain raphe nuclei.
Topics: Alkaloids; Animals; Apomorphine; Dextroamphetamine; Harmine; Levodopa; Male; Mesencephalon; Nervous System Physiological Phenomena; Neural Pathways; Rats; Serotonin; Serotonin Antagonists; Tremor | 1976 |
Parkinson's disease-like effects of S-adenosyl-L-methionine: effects of L-dopa.
Topics: Animals; Behavior, Animal; Histocytochemistry; Injections, Intraventricular; Levodopa; Male; Nerve Degeneration; Parkinson Disease, Secondary; Psychomotor Performance; Rats; Rats, Sprague-Dawley; S-Adenosylmethionine; Substantia Nigra; Tremor; Tyrosine 3-Monooxygenase | 1992 |
Isolated tremor and disruption of the nigrostriatal dopaminergic system: an 18F-dopa PET study.
Topics: Adult; Aged; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; Humans; Levodopa; Middle Aged; Parkinson Disease; Posture; Reference Values; Substantia Nigra; Tomography, Emission-Computed; Tremor | 1992 |
[Pharmacological effects of the novel dopamine uptake inhibitor 1-[2-[bis(4-fluorophenyl)-methoxy]ethyl]-4-(3-phenylpropyl) piperazine dihydrochloride (I-893) on the central nervous system].
Topics: Animals; Barbiturates; Body Temperature; Catalepsy; Dogs; Dopamine; Dose-Response Relationship, Drug; Electroencephalography; Haloperidol; Levodopa; Male; Methamphetamine; Mice; Motor Activity; Neurotransmitter Uptake Inhibitors; Piperazines; Rabbits; Rats; Rats, Inbred Strains; Sleep; Tremor; Tremorine | 1991 |
Stereotactic ventrolateralis thalamotomy for medically refractory tremor in post-levodopa era Parkinson's disease patients.
Topics: Adult; Aged; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Postoperative Complications; Stereotaxic Techniques; Thalamus; Tremor | 1991 |
Paroxysmal tremor and orofacial dyskinesia secondary to a biopterin synthesis defect.
Topics: Administration, Oral; Biopterins; Extremities; Humans; Infant; Levodopa; Male; Mouth; Movement Disorders; Phenylalanine; Tremor | 1991 |
Stereotaxic thalamotomy--experiences from the levodopa era.
Topics: Aged; Disability Evaluation; Follow-Up Studies; Humans; Levodopa; Middle Aged; Multiple Sclerosis; Parkinson Disease; Postoperative Complications; Stereotaxic Techniques; Thalamus; Tremor | 1990 |
Apomorphine in the diagnosis and treatment of parkinsonian tremor.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Apomorphine; Female; Humans; Injections, Subcutaneous; Levodopa; Male; Middle Aged; Parkinson Disease; Tremor | 1990 |
Marijuana for parkinsonian tremor.
Topics: Antiparkinson Agents; Apomorphine; Carbidopa; Diazepam; Drug Combinations; Humans; Levodopa; Marijuana Smoking; Parkinson Disease; Tremor | 1990 |
Tremors in early Parkinson's disease.
Topics: Carbidopa; Female; Humans; Levodopa; Male; Middle Aged; Oxazines; Parkinson Disease; Tremor | 1989 |
A selective potentiation by naloxone of L-dopa but not atropine suppression of oxotremorine-induced tremor in mice.
Topics: Animals; Atropine; Drug Synergism; Levodopa; Male; Mice; Mice, Inbred ICR; Naloxone; Oxotremorine; Time Factors; Tremor | 1985 |
The treatment of tremor.
Topics: Adrenergic beta-Antagonists; Alcoholic Beverages; Cerebellar Diseases; Humans; Isoniazid; Levodopa; Parkinson Disease; Primidone; Pyridoxine; Tremor | 1987 |
Comprehensive care of the patient with Parkinson's disease.
Topics: Aged; Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Humans; Levodopa; Male; Muscle Rigidity; Parasympatholytics; Parkinson Disease; Patient Care Planning; Patient Care Team; Tremor | 1986 |
Experimental study on resting tremor and L-dopa-induced dyskinesia.
Topics: Animals; Cercopithecus; Corpus Striatum; Disease Models, Animal; Dyskinesia, Drug-Induced; Levodopa; Macaca; Movement Disorders; Receptors, Dopamine; Receptors, Dopamine D2; Tegmentum Mesencephali; Tremor | 1987 |
Individual manifestations of Parkinson's disease after ten or more years of levodopa.
Topics: Gait; Handwriting; Humans; Levodopa; Middle Aged; Muscle Rigidity; Parkinson Disease; Posture; Prognosis; Speech; Time Factors; Tremor | 1986 |
Young onset Parkinson's disease.
Topics: Adult; Age Factors; Circadian Rhythm; Dementia; Dyskinesia, Drug-Induced; Humans; Levodopa; Middle Aged; Parkinson Disease; Pedigree; Risk Factors; Tremor | 1987 |
Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rat.
Topics: Animals; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Female; Haloperidol; Levodopa; Monoamine Oxidase Inhibitors; Movement Disorders; Muscle Rigidity; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Reserpine; Swimming; Sympatholytics; Time Factors; Tremor | 1987 |
Bromocriptine: long-term low-dose therapy in Parkinson's disease.
Topics: Adult; Aged; Bromocriptine; Drug Administration Schedule; Female; Humans; Levodopa; Male; Middle Aged; Movement; Muscle Rigidity; Parkinson Disease; Tremor | 1986 |
An analysis of long-term L-dopa therapy in 122 cases of Parkinson's disease over 14 years--when should L-dopa therapy be initiated?
Topics: Adult; Aged; Female; Gait; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Muscle Rigidity; Parkinson Disease; Prognosis; Receptors, Dopamine; Time Factors; Tremor | 1986 |
[Clinical subtypes of Parkinson disease].
Topics: Dementia; Diagnosis, Differential; Follow-Up Studies; Humans; Levodopa; Neuropsychological Tests; Parkinson Disease; Tremor | 1986 |
L-dopa-induced asterixis.
Topics: Aged; Electroencephalography; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Tremor | 1985 |
Parkinson disease. Individualizing therapy.
Topics: Aged; Bromocriptine; Carbidopa; Central Nervous System Diseases; Diagnosis, Differential; Gait; Humans; Levodopa; Male; Motor Activity; Parkinson Disease; Psychoses, Substance-Induced; Tremor | 1985 |
Failure of SKF 38393-A to relieve parkinsonian symptoms induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmoset.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Benserazide; Benzazepines; Callitrichinae; Levodopa; Male; Movement Disorders; Parkinson Disease, Secondary; Pyridines; Tremor | 1985 |
Central cholinergic-dopaminergic interaction in carbaryl-induced tremor.
Topics: Animals; Atropine; Carbaryl; Carbidopa; Dose-Response Relationship, Drug; Drug Synergism; Haloperidol; Levodopa; Male; Rats; Receptors, Cholinergic; Receptors, Dopamine; Tremor | 1985 |
Pharmacologic treatment of parkinsonian tremor.
Topics: Amantadine; Carbidopa; Drug Combinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Tremor; Trihexyphenidyl | 1986 |
Oxotremorine-induced cholinergic syndrome: modifications by levodopa and/or oral cytidine diphosphocholine.
Topics: Administration, Oral; Animals; Choline; Cytidine Diphosphate Choline; Diarrhea; Female; Hypothermia; Levodopa; Mice; Oxotremorine; Salivation; Syndrome; Tremor | 1985 |
Clonidine in essential tremor: preliminary observations from an open trial.
Topics: Aged; Clonidine; Diazepam; Female; Handwriting; Humans; Levodopa; Male; Middle Aged; Piribedil; Tremor | 1985 |
Combined resting-postural tremors.
Topics: Aged; Ethanol; Female; Humans; Levodopa; Male; Middle Aged; Posture; Propranolol; Rest; Tremor; Trihexyphenidyl | 1985 |
Failure of postictal growth hormone rise in a patient with thalamic lesions.
Topics: Adult; Arginine; Brain Diseases; Circadian Rhythm; Growth Hormone; Humans; Levodopa; Male; Postoperative Complications; Seizures; Sleep Stages; Stress, Physiological; Thalamus; Tremor | 1985 |
Evidence for the functional interaction of two central neurotransmitters.
Topics: Anilides; Animals; Behavior, Animal; Cinnamates; Dopamine; Dopamine Antagonists; Drug Interactions; Fenclonine; Levodopa; Male; Methyltyrosines; Methysergide; Muscle Rigidity; Neurotransmitter Agents; Pargyline; Pimozide; Rats; Serotonin; Serotonin Antagonists; Sulfides; Synaptic Transmission; Tremor; Tryptophan | 1974 |
Dopaminergic and cholinergic mechanisms in relation to postural tremor in the monkey and circling movements in the cat.
Topics: Acetylcholine; Amphetamine; Animals; Cats; Corpus Striatum; Disease Models, Animal; Dopamine; Frontal Lobe; Haloperidol; Haplorhini; Levodopa; Mesencephalon; Methyltyrosines; Mice; Movement Disorders; Parkinson Disease; Posture; Rats; Reserpine; Substantia Nigra; Tegmentum Mesencephali; Thalamic Nuclei; Tremor | 1974 |
Possible role of cerebellar circuits in parkinsonian symptoms.
Topics: Aged; Animals; Cats; Cerebellar Diseases; Cerebellum; Female; Haplorhini; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Muscle Rigidity; Neural Pathways; Parkinson Disease; Thalamic Nuclei; Tremor | 1974 |
Drug treatment of diseases characterized by abnormal movements.
Topics: Chorea; Diazepam; Ethanol; Haloperidol; Humans; Huntington Disease; Levodopa; Movement Disorders; Myoclonus; Phenothiazines; Propranolol; Reserpine; Tetrabenazine; Tic Disorders; Torticollis; Tourette Syndrome; Tremor | 1973 |
Mechanisms involved in the control of extrapyramidal dysfunctions and in striatal dopamine synthesis.
Topics: Animals; Antiparkinson Agents; Apomorphine; Basal Ganglia Diseases; Bucladesine; Carbidopa; Carbon Radioisotopes; Corpus Striatum; Depression, Chemical; Dopamine; Drug Therapy, Combination; Haloperidol; Haplorhini; Levodopa; Receptors, Drug; Stimulation, Chemical; Tremor | 1974 |
Importance of the cerebellar hemisphere in production of tremulous movement or choreo-dystonic movement in monkeys.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Cerebellum; Chorea; Disease Models, Animal; Drug Combinations; Enzyme Inhibitors; Levodopa; Macaca; Muscular Diseases; Tremor | 1974 |
Arousal response in hepatic encephalopathy with L-Dopa.
Topics: Aged; Arousal; Female; Hepatic Encephalopathy; Humans; Intelligence; Levodopa; Male; Middle Aged; Tremor; Unconsciousness | 1974 |
L-DOPA: chemical modifications and biological evaluation.
Topics: Animals; Antiparkinson Agents; Blepharoptosis; Catatonia; Disease Models, Animal; Humans; Hypothermia; Levodopa; Male; Mice; Oxotremorine; Parkinson Disease; Reserpine; Structure-Activity Relationship; Tremor | 1974 |
Parkinsonism as a falling sickness.
Topics: Age Factors; Aged; Amantadine; Female; Gait; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Muscle Rigidity; Neurologic Examination; Parasympatholytics; Parkinson Disease; Posture; Reflex; Remission, Spontaneous; Tremor | 1974 |